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Abstract 
Background: The duration of untreated psychosis (DUP) is negatively associated with 
objective recovery among people with first-episode psychosis (FEP). However, the 
association between DUP and subjective recovery is not known. Objectives: To investigate 
whether DUP is statistically associated with self-perceived recovery scores (subjective 
recovery) and occupational activity (objective recovery) 10-years after the first episode of 
psychosis. Methods: A cohort of 65 clients from an early intervention program completed a 
battery of outcome measures 10-years following initial treatment for FEP (March 1997 to 
February 2002). Multiple linear or logistic regression analyses were used to estimate the 
association between DUP and both measures of recovery, adjusting for potential confounding 
factors. Results: We did not find a statistically significant association between between DUP 
and either weeks of occupational activity (OR = 1.26, 95%CI: 0.81 to 1.95) or self-perceived 
recovery score (ß = -0.73, 95%CI: -2.42 to 0.97), adjusting for 10-year confounding factors. 
However, we found a negative association between negative symptoms at 10-year follow-up 
and occupational activity (OR = 0.69, 95%CI: 0.57 to 0.84), as well a positive association 
between perceived social support score at 10-year follow-up and self-perceived recovery 
score (ß = 0.94, 95%CI: 0.45 to 1.42), adjusting for 10-year confounding factors. 
Conclusions: Our findings suggest that factors other than DUP have an impact on objective 
and subjective recovery at 10-year follow-up. Further research examining factors associated 
with self-perceived recovery after a first episode of psychosis is warranted.  
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Chapter 1!!
1! Background & Introduction  
In this chapter, the overall purpose of this thesis is provided in Section 1.1, followed by 
background information about psychosis, first-episode psychosis, and early intervention 
programs in Sections 1.2, 1.3, and 1.4, respectively. Thereafter in Section 1.5, the 
rationale for this thesis is provided, followed by a brief description of our thesis 
objectives in Section 1.6. Next in Section 1.7, the data source is described. Subsequently 
in Section 1.8, the contributions to this thesis are outlined. Lastly, an overview of the 
chapters in this manuscript is provided in Section 1.9.   
1.1! Overall Purpose   
The overall purpose of this thesis is to investigate whether the length of time psychosis is 
left untreated is associated with a person’s judgement of his or her recovery from first-
episode psychosis at 10-year follow-up.  
1.2! Background Information: Psychosis  
1.2.1! Psychosis Overview  
Psychosis is a syndrome or a set of symptoms; it is not a mental health diagnosis or 
disease (Keks & Blashki, 2006). A range of symptoms characterize psychosis, and these 
symptoms are typically categorized as either “positive” (present or added on) or 
“negative” (absent or reduced), and are often referred to as “psychotic symptoms” or 
“symptoms of psychosis” (Jones, Hacker, Cormac, Meaden, & Irving, 2012; Minas et al., 
1992). Examples of positive symptoms include delusions, which are false, unjustified 
beliefs and judgments, and hallucinations which involves seeing, hearing, tasting, or 
smelling something that is not actually present (American Psychiatric Association, 2013). 
Examples of negative symptoms include reduction in speech and difficulty in thinking 
(American Psychiatric Association, 2013). In general, these symptoms change a person’s 
state of mind in which he or she is unable to differentiate what is real (American 
Psychiatric Association, 2013), and the person is often described as being “out of touch 
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with reality” or having a “distorted perception of reality.” The number, type, and severity 
of psychotic symptoms can vary from person to person depending on the underlying 
cause of psychosis.  
There are a number of potential causes of psychosis. These include, but are not limited to 
alcohol and drug (e.g., cocaine) use or withdrawal, brain injury, other health conditions 
(e.g., epilepsy), intense stress, or an underlying mental illness (American Psychiatric 
Association, 2013). In this thesis, psychosis as a consequence of a mental illness will be 
considered, which may occur in the context of several different psychiatric disorders, 
including schizophrenia, delusional disorder, bipolar disorder, or depression with 
psychotic features. These are typically classified as either non-affective (e.g., 
schizophrenia) versus affective (e.g., bipolar disorder) (e.g., ElTayeban, ElGamal, 
Roshdy, & Al-Khadary, 2014; Salvatore et al., 2007) or as schizophrenia-spectrum versus 
other psychotic disorder (American Psychiatric Association, 2013).  
It has been estimated that approximately 3% of the general population will experience 
psychosis at some point over the course of their lifetime (Perala et al., 2007). Typically, 
people experience their first episode of psychosis in their late teens and early twenties 
(Kessler et al., 2007). During this period of late adolescence and early adulthood, 
personal and professional development and growth occurs (Harris et al., 2005; Mackrell 
& Lavender, 2004), which can potentially be disrupted by the onset of psychosis, 
consequently having a negative impact on the person and his or her family (Reed, 2008). 
Fortunately, psychosis can be treated, with earlier treatment resulting in better outcomes 
(Marshall et al., 2005; Perkins, Gu, Boteva, & Lieberman, 2005). In addition, some 
people will never experience psychosis (i.e., psychotic episode) again and do recover, 
whereas other suffer a relapse and may or may not recover (Robinson et al., 1999).  
1.2.2! Phases of Psychosis  
An episode of psychosis typically occurs in three phases, beginning with the prodrome 
(or prodromal) phase, followed by the acute phase, and ending with the recovery phase 
(Figure 1.1). The duration of each phase varies from person to person. During the 
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prodrome, the person experiences gradual non-specific changes in thoughts, feelings, and 
behaviours such as sleep disturbance, depressed mood, irritability, reduced concentration, 
drive, and motivation (Yung & McGorry, 1996). During the acute phase, a person 
experiences hallucinations, delusions, or other symptoms of psychosis for which 
treatment should be sought immediately to prevent any further interference in the 
different domains of a person’s life. During the final phase, the recovery phase, 
symptoms of psychosis alleviate or disappear completely, allowing the person to better 
cope with daily life and resume roles or activities that he or she was engaged in prior to 
the psychotic episode (Davidson, O’Connell, Tondara, Lawless, & Evans, 2005).   
 
Figure 1.1: Phases of Psychosis. 
Importantly, the last phase highlights that recovery after a psychotic episode is possible; 
however, it is highly variable (de Koning et al., 2009; Marshall & Rathbone, 2011). 
While some may recover after a psychotic episode, others do not. Even among those that 
do recover, some may suffer one or more relapses, and may or may not recover again.  
It is also important to highlight that the elimination or reduction of psychotic symptoms 
does not directly equate with a person being in the recovery phase. Although remission of 
symptoms is seen as a sign of recovery for some, for others it is either not acknowledged 
as a sign of recovery or it is one of many signs of recovery that have yet to be attained 
such as regaining previous social functions, cognitive functions, or trust in others 
(Eisenstadt, Monteiro, Diniz, & Chaves, 2012; Lam et al., 2010; Windell, Norman, & 
Malla, 2012).  
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1.3! Background Information: First-Episode Psychosis  
1.3.1! Definition  
First-episode psychosis has garnered increased research and clinical interest over the past 
two decades, although significant heterogeneity exists in how it is operationalized. 
Typically, it is operationalized based on one of the following three definitional 
categories: (i) the first treatment contact for a psychotic disorder; (ii) antipsychotic 
medication use for a specified length of time; (iii) the duration of psychotic symptoms 
(Breitborde, Srihari, & Woods, 2009). 
Regardless of the definitional category that is used, first-episode psychosis, in general, 
refers to a person who is in the early stage of a psychotic illness and who has received 
minimal or no prior treatment (Breitborde, Srihari, & Woods, 2009).  
1.3.2! Incidence  
A recent study conducted by Anderson and colleagues (2012) estimated the age and 
gender standardized annual incidence of first-episode schizophrenia-spectrum psychosis 
in Quebec among people aged 14 to 25 years to be 82.9 per 100 000 for males and 32.2 
per 100 000 for females. A 3-year period (2004-2006) was used to identify people with 
first-episode schizophrenia (Anderson, Fuhrer, Abrahamowicz, & Malla, 2012). 
Approximately 65% of people with first-episode psychosis present with schizophrenia-
spectrum, which includes diagnoses such as schizophrenia, schizophreniform disorder, 
schizoaffective disorder, or delusional disorder (Kirkbridge et al., 2006; Proctor, Mitford, 
& Praxton, 2004; Reay, Mitford, McCabe, Paxton, & Turkington, 2010).  
1.4! Background Information: Early Intervention Programs 
Over the past 20 years, an increasing number of specialized early intervention programs 
have been developed and implemented in countries around the world, including Canada 
(Edwards & McGorry, 2002; McGorry, Killackey, & Yung, 2008), which has at least one 
such program in each of the 10 provinces, with more than 60 programs across the 
province of Ontario. The proliferation of these programs may in part be attributed to the 
growing interest in improving outcomes through early detection of positive symptoms 
5 
 
and the use of pharmacological, psychosocial, and/or vocational interventions targeting 
the first two to five years after the onset of a first episode of psychosis, a critical period 
(Birchwood, Todd, & Jackson, 1998; McGorry et al., 2007).  
During the initial critical period, trajectories of outcomes are generally defined (Harrison 
et al., 2001) and rates of relapse are relatively high (i.e., approximately 80%) (Bergé et al. 
2015; Robinson et al., 1999). It is therefore not surprising that two of the primary 
objectives of these programs are to alter the negative trajectory of outcomes by reducing 
the duration of untreated psychosis through early detection and prompt initiation of 
treatment (Singh & Fisher, 2005), and by preventing relapse (Alvarez-Jimenez et al., 
2012; Robinson et al., 1999; Schooler et al., 2005).  
1.4.1! Shorten the Duration of Untreated Psychosis  
A long duration of untreated psychosis is associated with a range of poor outcomes 
(Norman & Malla, 2001; Norman et al., 2005; Marshall et al., 2005; Perkins et al., 2005); 
however, it is one of the few modifiable prognostic factors of poor outcome (Chang et al., 
2012b; Singh & Fisher, 2005). Therefore, the primary aim of specialized early 
intervention programs is to improve outcomes in people with a first episode of psychosis 
by shortening the duration of untreated psychosis through early detection and treatment 
(Chang et al., 2012b; Singh & Fisher, 2005).  
There does appear to be some uncertainty as to whether the effects of shortening the 
duration of untreated psychosis are sustained over the long-term, which may in part be 
attributed to the limited number of prospective outcome studies with follow-up periods of 
10-years or more. There also appears to be some emerging interest in the association 
between the duration of untreated illness and poor outcome, which is the length of time 
between the onset of any earlier non-psychotic signs of illness and initiation of treatment 
(Crumlish et al., 2009), which has been found to be more consistently associated with 
poor outcome than the duration of untreated psychosis (e.g., Crumlish et al., 2009; 
Dell’Osso, Glick, Baldwin, & Altamura, 2012; Harris et al., 2005; Keshavan et al., 2003; 
Norman et al., 2012). As a result, many specialized early intervention programs are also 
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now targeting people believed to be in the prodromal phase of psychosis, or at an ultra-
high risk for developing a psychotic disorder (de Koning et al., 2009).  
1.4.2! Relapse Prevention  
Vulnerability to relapse is high during the first 5-years following initial onset (Bergé et 
al., 2015), with most people experiencing a relapse at least once during the two to five-
year period (Gitlin et al., 2001; Robinson et al., 1999). Moreover, the cumulative 
incidence is 80% at 5-year follow-up (Robinson et al., 1999).  
Prevention of relapse is important because experiencing a relapse can potentially result in 
disengagement from meaningful activities (e.g., school or work) and from family or 
friends, which can adversely impact a person’s psychosocial and vocational development 
(Penn, Waldheter, Perkins, Mueser, & Lieberman, 2005), and may impede recovery. 
Clinically, prevention of relapse is important because a future response to treatment such 
as antipsychotic medication may potentially be reduced after each relapse (Tibbo, Malla, 
Manchanda, Williams, & Joober, 2014), and progressive gray matter loss may occur 
based on the durations of relapses (Andreasen, Liu, Ziebell, Vora, & Ho, 2013).  
Targeting modifiable risk factors (e.g., duration of untreated psychosis) has been 
suggested to contribute to the relatively lower relapse rates observed among people 
treated and followed-up in an early intervention program for psychosis, compared to 
those in routine care (Malla, Norman, Bechard-Evanc, Schmitz, Manchanda, & Cassidy, 
2008). Despite the lower rates (i.e., 20% to 30% during 2-years), risk of relapse continues 
be a barrier to recovery (Malla et al., 2008; Tibbo, Malla, Manchanda, Williams, & 
Joober, 2014). Moreover, identification of factors associated with relapse has been 
suggested to facilitate the development of effective prevention strategies (Hui et al., 
2013).  
1.5! Study Rationale  
With emerging clinical and research interest in the assessment of recovery as an outcome 
among people with first-episode psychosis, identification of factors that may impede 
recovery is important to promote, as well as sustain recovery. Given that the duration of 
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untreated psychosis has been identified as one of the few modifiable risk factors of poor 
outcome in people with first-episode psychosis, its relationship to recovery is of interest. 
However, the existing literature on the relationship between duration of untreated 
psychosis and recovery has focused on one dimension of recovery, objective recovery, 
and this relationship has been assessed over a short period of time (< 10-years). To 
addresses the current gaps in the literature, we investigated whether the duration of 
untreated psychosis is associated with the other dimension of recovery, subjective 
recovery, and we assessed this relationship over a 10-year follow-up period.  
1.6! Thesis Objectives  
Using data from 65 clients of an early intervention program who received initial 
treatment for a first episode of psychosis at least 10-years ago, the four objectives of this 
thesis were:  
1.! To examine the association between objective and subjective measures of 
recovery at 10-year follow-up.  
2.! To investigate whether the duration of untreated psychosis is associated with 
objective recovery, adjusting for potential confounding variables.  
3.! To examine whether the duration of untreated psychosis is associated with 
subjective recovery, adjusting for potential confounding variables. 
4.! To investigate whether relapse mediates the relationship between the duration of 
untreated psychosis and subjective recovery, adjusting for potential confounding 
variables.  
A detailed description of each of these four objectives and hypotheses will be provided in 
Chapter 2, with reference to our conceptual framework.  
1.7! Data Source: PEPP Data Set  
The data used in this thesis came from a prospective cohort study (i.e., source study) 
titled, “Assessment of 10 Year Outcomes for Clients of the Prevention and Early 
Intervention Program for Psychoses (PEPP).” The purpose of this study was to assess 
outcomes of clients 10-years following initial treatment for a first episode of psychosis at 
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PEPP (London, Canada). Primary outcomes assessed were levels of positive and negative 
symptoms, level of functioning, and self-perceived recovery. Secondary outcomes 
assessed were dysfunctional attitudes, neurocognition, self-stigma, and self-efficacy.  
The five main objectives of this study included: 
1.! Compare 10-year outcomes with those at 5-year follow-up. 
2.! Identify early predictors of 10-year outcomes. 
3.! Examine outcomes not previously assessed in earlier follow-up assessments with 
the same cohort of clients. 
4.! Assess the degree of correspondence between symptomatic, functional, and 
subjective measures of outcome.  
5.! Examine in greater detail the nature of negative symptoms at 10-years, and 
examine the correlates/predictors of variation in these symptoms. 
Objectives 1 to 3 of this thesis aligned with two of the five main objectives of the source 
study, specifically objectives 2 and 4.  
1.8! Contributions to Current Study  
My contribution to the current study began with selecting our exposure and outcome 
variables of interest in collaboration with Dr. Kelly Anderson, my thesis supervisor, and 
Dr. Ross Norman, the primary investigator of the source study. I then formulated the 
thesis objectives and corresponding hypotheses in collaboration with Drs. Anderson and 
Norman. Thereafter, I proposed a statistical analysis plan for each of the objectives with 
consultation from Dr. Anderson. The statistical analysis plan included adjustment of 
potential confounding variables in our preplanned statistical analyses, which were 
identified as such from a conceptual framework that Dr. Anderson and I created, based on 
available data. The objectives and statistical analysis plan were reviewed by Dr. Norman 
to ensure that we did not miss anything from a clinical perspective. Dr. Neil Klar, a 
member of my thesis supervisory committee, also reviewed the objectives and statistical 
analysis plan to check for feasibility and to ensure that we did not miss anything from a 
statistical perspective. Upon approval from Drs. Norman and Klar, I submitted a request 
for access to a subset of the variables. After I received the data set from Dr. Norman, I 
‘cleaned’ the data (Chapter 3), examined the amount of missing data using several 
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approaches (Chapter 3), selected a method to handle missing data (i.e., multiple 
imputation) with consultation from Drs. Anderson and Klar, and then assessed for multi-
collinearity. Thereafter, I conducted all analyses and interpreted findings with 
consultation from Dr. Anderson. Lastly, my contribution ended with the writing of this 
manuscript. The critical revision of this manuscript for content, structure, writing clarity 
and quality was an on-going process that involved Drs. Anderson and Klar.  
1.9! Overview of Thesis Chapters 
The current study will be described in greater detail in the next four chapters:       
Chapter 2 provides a detailed description of the duration of untreated psychosis, our 
exposure variable of interest, and recovery (i.e., objective and subjective recovery), our 
outcome variable of interest. It also summarizes the existing literature assessing the 
association between these variables in people who were initially treated at an early 
intervention program for either a first episode of psychosis or a first episode of 
schizophrenia.                                                                                                              
Chapter 3 describes the study procedures of the source study, along with the variables 
and measures included in the data set. It then provides an overview of the multiple 
imputation method used to handle missing data, and it outlines our statistical analysis 
plan comprised of a point biserial correlation, a multiple logistic regression analysis, a 
multiple linear regression analysis, and a mediation analysis for objectives 1, 2, 3, and 4, 
respectively.   
 Chapter 4 presents findings from the main analyses that included data from a cohort of 
65 clients of PEPP, which were analyzed using Stata (version 14). It then presents 
findings from the two sets of sensitivity analyses that involved the use of complete data, 
as well as the use of imputed data with the duration of untreated illness as the exposure 
variable in place of the duration of untreated psychosis.  
Chapter 5 discusses key findings, including the following statistically significant 
findings: (i) duration of untreated psychosis is not associated with both measures of 
recovery, whereas the duration of untreated psychosis is associated with both measures of 
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recovery; (ii) perceived social support is positively associated with subjective recovery; 
(ii) negative symptoms are negatively associated with objective recovery. It then 
highlights that in a clinical context, a more comprehensive overview of a person’s 
recovery after a first episode of psychosis is attained by assessing different dimensions of 
recovery, and factors other than the duration of untreated psychosis need to be targeted to 
enhance a person’s subjective and objective recovery from a first episode of psychosis. 
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Chapter 2!!
2! Literature Review  
In this chapter, a detailed description of the duration of untreated psychosis and recovery 
is provided in Sections 2.1 and 2.2, respectively. In Section 2.3, the existing literature on 
the association between the duration of untreated psychosis and recovery is summarized. 
In Section 2.4, gaps in the existing literature are discussed. Thereafter, in Section 2.5, our 
conceptual framework is presented. Lastly, a detailed description of the thesis objectives 
and hypotheses with reference to the conceptual framework is provided in Section 2.6.  
2.1! Duration of Untreated Psychosis 
2.1.1! Definition, Components, & Measurement  
Definition 
The duration of untreated psychosis (DUP) or treatment delay is generally defined as the 
time interval (t1 < DUP < t2) between the onset of psychotic symptoms (e.g., positive 
symptoms such as hallucinations and delusions; t1) and the initiation of adequate 
treatment (e.g., antipsychotic medication for a period of 1 month; t2) (Compton et al., 
2007; Ienciu, Romoşan, Bredicean, & Romoşan, 2010; Malla, Norman, Scholten, & 
Manchanda, 2005; McGlashan, 1999; Tang et al., 2014). Essentially, the duration of 
untreated psychosis measures ‘delay in treatment’ for psychosis (Malla, Norman, 
Scholten, & Manchanda, 2005). Thus, the terms ‘duration of untreated psychosis’ and 
‘treatment delay’ are often used interchangeably. A list of other synonyms is provided in 
Appendix A.  
Components 
The duration of untreated psychosis can be conceptualized as being comprised of three 
temporally separate components: 1) A help-seeking component (i.e., Help-Seeking 
Delay), defined as the time interval between the onset of psychotic symptoms and first 
contact with health services (e.g., general practitioner); 2) A referral component (i.e., 
Referral Delay), defined as the time interval between first contact with health services 
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and referral to mental health care services; and 3) A mental health care services 
component (i.e., Delay in Mental Health Care Service), defined as the time interval 
between referral to mental health care services and initiation of adequate treatment 
(Figure 2.1) (Boonstra, Sterk, Wunderink, Sytema, De Haan, & Wiersma, 2012; Brunet, 
K., Birchwood, M., Lester, H., & Thornhill, 2007). A recent review of the multifaceted 
determinants of the duration of untreated psychosis suggests that patient-, illness-, and 
family level factors are more likely to influence the help-seeking component of the 
duration of untreated psychosis, whereas system-level factors are more likely to influence 
the referral component of the duration of untreated psychosis (Compton & Broussard, 
2011). Some of these factors are modifiable, whereas others are not. Factors that 
influence and/or are more likely to influence the mental health care services component 
of the duration of untreated psychosis have not readily been investigated. However, 
Boonstra and colleagues (2012) reported that delay in mental health care service was 
significantly longer for people with first-episode psychosis who not only already received 
treatment for other diagnoses from a mental health care service, but also for those living 
in rural areas compared to those living in urban areas.  
 
Figure 2.1: Components of DUP. Note: This figure is modified from French, Smith, 
Shiers, Reed, & Rayne (2010). DUP = Duration of Untreated Psychosis; t1 = time-point 
one, which corresponds to the onset of DUP; t2 = time-point two, which corresponds to 
the endpoint of DUP. 
 
13 
 
Measurement  
Measurement of the duration of untreated psychosis (t1 < DUP < t2) involves estimating 
the length of time (e.g., weeks) that has elapsed between the onset of the duration of 
untreated psychosis (t1) and the endpoint of the duration of untreated psychosis (t2) 
(Compton, 2007; Norman & Malla, 2001) (Figure 2.1). The duration of untreated 
psychosis estimates obtained will vary depending on how the onset (t1) and the endpoint 
(t2) are operationalized (Compton, 2007; Norman & Malla, 2001). Variation in the 
operationalization of the onset and endpoint of the duration of untreated psychosis is 
apparent in studies included in Table 2.1. For instance, operationalization of the onset of 
the duration of untreated psychosis included the onset of first positive psychotic 
symptoms or psychosis onset (Evensen et al., 2012; Friis et al., 2015). Operationalization 
of the endpoint of the duration of untreated psychosis included initiation of antipsychotic 
medication or hospitalization (Compton, 2007; Friis et al., 2015; Jaracz et al., 2015). 
Variation in the operationalization of the onset and endpoint of the duration of untreated 
psychosis makes comparison across studies difficult.  
Definition of DUP in this Thesis  
We defined the duration of untreated psychosis as the length of time in weeks between 
the date of onset of positive psychotic symptoms (e.g., hallucination) to the date of 
initiation of adequate treatment. Adequate treatment referred to treatment with 
antipsychotic medication for 1-month (or until symptoms have resolved) or psychosocial 
treatment (i.e., assertive case management) for 1-month. These dates were extracted from 
select items from the Course of Onset or Relapse Schedule (CORS; Norman & Malla, 
2002). 
2.1.2! Influence of DUP on Outcomes  
There have been two systematic reviews of the literature specifically investigating the 
link between the duration of untreated psychosis and outcome in people with either first-
episode psychosis or first-episode schizophrenia (Marshall et al., 2005; Perkins, Gu, 
Boteva, & Lieberman, 2005). With the exception of one study, both reviews consisted of 
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studies with follow-up periods of two-years or less. The conclusions of each review were 
consistent: A longer duration of untreated psychosis is associated with poorer short-term 
outcomes (Marshall et al., 2005; Perkins, Gu, Boteva, & Lieberman, 2005). It remains 
unclear whether the duration of untreated psychosis is associated with long-term (> 10-
years) outcomes, attributed in part to the limited number of empirical studies with follow-
up periods of 10-years or more. 
We conducted a literature search of studies examining the association between the 
duration of untreated psychosis and long-term (> 10-years) outcomes in people with first-
episode psychosis or first-episode schizophrenia. Table 2.1 summarizes study 
characteristics and main findings of studies identified by our literature search.  
All studies (n = 12) were conducted in countries other than Canada and were published 
between 2005 and 2016. Of all the studies, half of the studies (n = 6) had a length of 
follow-up of 10-years (Austin et al., 2015; Evensen et al., 2012; Friis et al., 2016; Rund et 
al., 2015; Shrivastava et al., 2010; White et al., 2009), while a majority of the remaining 
studies (n = 4) had a length of follow-up of more than 10-years (Hill et al., 2012; Ichinose 
et al., 2010; Röpcke & Eggers, 2005; Tang et al., 2014), and the remaining few studies  
(n = 2) had lengths of follow-up of both 10 and more than 10-years (Jaracz et al., 2015; 
Kinoshita et al., 2005). The rate of follow-up ranged from 29% (Ichinose et al., 2010) to 
87% (Rund et al., 2015), and the sample size ranged from 31 (Ichinose et al., 2010) to 
304 (Austin et al., 2015). The mean duration of untreated psychosis ranged from 6 to 88 
weeks (Evensen et al., 2012; Hill et al., 2012). 
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Table 2.1: Summary of Studies (n = 12) Examining the Relationship between DUP and Long-Term (> 10-years) Outcomes in People with 
First-Episode Psychosis or First-Episode Schizophrenia. 
 
 
Study 
Authors 
(Year) 
Country 
 
Sample Source Length of 
Follow-up 
Sample 
Size at 
Follow-up 
Rate of 
Follow-up 
n/total (%) 
Measurement of DUP 
 
                                                         
   Onset                      Endpoint 
DUP 
Categorization 
Mean 
DUP 
Outcome(s)/ 
Outcome Measures 
 
Relationship between 
DUP & Outcome(s) 
[Yes/No] 
Kinoshita   
et al. 
(2005) 
Japan Psychiatric Care 
Organizations 
(Private mental 
hospitals, Prefectural 
mental hospital, Private 
Psychiatry Clinics, 
Public General 
Hospitals, and Health 
Centers)  
10 & 15 
years 
52 Patients 
with First-
Episode 
Schizophrenia  
 
52/97      
(54%) 
Onset of 
illness  
Initial visit at a 
medical 
facility  
 9.9 
months 
Good Outcome =  
Complete remission 
with or without 
relapse  
Poor Outcome =  
Incomplete remission 
with or without 
relapse or continuous 
psychotic illness  
A long DUP was 
significantly associated 
with poor outcome at 
10-year follow-up, but 
not at 15-year follow-
up.  
Röpcke & 
Eggers  
(2005) 
Germany Outpatient Clinic for 
Child & Adolescent 
Psychiatry   
15.4 
years+  
39 Patients 
with a 
diagnosis of 
Early Onset 
Schizophrenia 
39/55     
(71%) 
Onset of first 
psychotic 
symptoms  
First 
antipsychotic 
treatment  
 Not 
provided 
Psychopathological 
and Social Outcome 
Clinical Global 
Impression (CGI), 
Psychosocial 
functioning (Global 
Assessment of Social 
Function, Negative 
Symptoms, Positive 
Symptoms, and 
General Psycho- 
pathology (PANSS)) 
DUP was not 
significantly associated 
with any of the 
outcomes at follow-up.  
White        
et al. 
(2009) 
United 
Kingdom 
National Health Service 
Psychiatric Units   
10 years 69 Patients 
with First-
Episode 
Psychosis  
69/109    
(63%) 
Onset of first 
positive 
psychotic 
symptoms  
Index 
admission   
24.68 
weeks 
Functional Outcome, 
Service Contact/ 
Dependency, & 
Outcome Symptom 
Burden  
DUP was independ-
ently associated with 
poor outcome 
symptom burden at 10-
year follow-up.  
          [Yes] 
Note: DUP = Duration of Untreated Psychosis; + = Mean length of follow-up (10.2-21.2 years); n = count; PANSS = Positive and Negative Syndrome Scale; CGI = Clinical Global Impression; & = 
and; % = Percentage.                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                        (Continued)                                                                                                                                                                                                
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Table 2.1: Summary of Studies (n =12) Examining the Relationship between DUP and Long-Term (> 10-years) Outcome in People with 
First-Episode Psychosis or First-Episode Schizophrenia. 
Study 
Authors 
(Year) 
Country 
 
Sample Source Length of 
Follow-up 
Sample 
Size at 
Follow-up 
 
Rate of 
Follow-up 
n/total (%) 
Measurement of DUP 
 
 
 
      Onset                      Endpoint 
DUP 
Categorization 
Mean 
DUP 
Outcome(s)/ 
Outcome Measures 
 
Relationship between 
DUP & Outcome(s) 
[Yes/No] 
Ichinose      
et al. 
(2010)*!
Japan! Medical Institutions with 
Psychiatry Departments 
(Private psychiatry 
hospitals & clinics, 
Prefectural psychiatry 
hospital, Public General 
Hospital Psychiatry 
Departments, and Health 
Centers)!
28 years! 31 Patients 
with First-
Episode 
Schizophrenia  !
31/107 
(29%)!
Disease Onset 
 
 
 !
Start of 
treatment at 
a medical 
institution !
Short DUP =        
< 3 months 
 
Long DUP =       
> 4 months!
8.97 
months!
Global Assessment 
Schedule (GAS), 
Disability Assessment 
Schedule (DAS), and 
Clinical Global 
Impression (CGI) 
!
A long DUP was 
significantly associated 
with decreased GAS, 
DAS, and CGI.          
             [Yes]!
Shrivastava 
et al.  
(2010) * 
India Non-Governmental 
Psychiatric Hospital 
10 years 101 
Hospitalized 
Patients with 
First-Episode 
Schizophrenia 
101/200    
(51%) 
Positive 
symptoms 
(hallucinations, 
delusions, odd 
beliefs, and 
thought disorder), 
negative 
symptoms 
(depression, 
dysphoria, apathy, 
anergia, apathy, 
and amotivation), 
and social decline 
(withdrawn 
behavior, poor 
interpersonal 
relationship, 
social avoidance, 
and lack of 
interest in 
education or 
work) 
Not 
Described    
Short DUP =     
< 12 months 
 
Long DUP =     
> 12 months 
 
12.7 
months 
Clinical: Clinical 
Global Impression, 
Psychopathology, 
Depressive 
Symptoms, Factors of 
Compliance, 
Extrapyramidal 
Symptoms, 
Aggression, 
Hospitalization, & 
Suicidality   
 
Social: Quality of 
Life, Global 
Functioning, 
Independent Living, 
Family Burden, & 
Social Burden 
DUP was not 
significantly associated 
with any of the clinical 
or social outcomes.    
                [No] 
 
  
Note: *DUP main focus; DUP; Duration of Untreated Psychosis; n = count; GAS = Global Assessment Schedule; DAS = Disability Assessment Schedule; CGI = Clinical Global 
Impression; & = and; % = Percentage.                                                                                                                                                                                                              (Continued)                                                                                                                                                                                                
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Table 2.1: Summary of Studies (n =12) Examining the Relationship between DUP and Long-Term (> 10-years) Outcome in People with 
First-Episode Psychosis or First-Episode Schizophrenia. 
Study 
Authors 
(Year) 
Country 
 
Sample Source Length of 
Follow-up 
Sample 
Size at 
Follow-up 
 
Rate of 
Follow-up 
n/total (%) 
Measurement of DUP 
 
 
 
     Onset                     Endpoint 
DUP 
Categorization 
Mean 
DUP 
Outcome(s)/ 
Outcome Measures 
 
Relationship between 
DUP & Outcome(s) 
[Yes/No] 
Evensen     
et al. 
(2012) 
 
!
Norway 
& 
Denmark!
The Treatment & 
Intervention in Psychosis 
Study (TIPS); Specialist 
Psychiatric Health-Care 
Services of four 
Scandinavian Health Care 
Sectors !
10 years! 178  First-
Episode 
Psychosis 
Patients 
(Inpatients & 
Outpatients)!
178/301  
(59%)!
First positive 
psychotic 
symptoms  
 
!
Start of the first 
adequate 
treatment of 
psychosis 
 
 
 
!
! 6 weeks! Apathy ! DUP was not 
significantly associated 
with self-rated apathy at 
10-years follow-up.  
               [No]!
Hill et al. 
(2012)* 
 
 
Ireland Cluain Mhuire Family 
Centre (provides 
psychiatric service) or the 
St John of God Hospital 
 
12 years 123 First-
Episode 
Psychosis 
Patients 
123/171 
(72%) 
Onset of the 
first psychotic 
symptom 
 
  
Start of 
antipsychotic 
treatment   
< 1 month; 
>1 and <3 
months; 
>3 months and 
<1 year; 
>1 year 
 
20.3 
months 
Symptomatic: Positive 
Symptoms, Negative 
Symptoms, 
Disorganized 
Symptoms, Symptom 
Severity, & Remission   
 
Functional: 
General/Global 
Functioning, Quality 
of Life, Level of 
Functioning, Social 
Functioning, & 
Occupational 
Functioning  
Longer DUP was 
significantly associated 
with poorer remission 
status, more severe 
positive and negative 
symptoms, and greater 
impairment in general 
functioning, social 
functioning, as well as 
quality of life. 
              [Yes] 
 
 
Tang      
et al. 
(2014)* 
 
 
Hong 
Kong 
Public Hospitals  13 years 96 First-
Episode 
Psychosis 
Patients   
96/153   
(63%) 
Onset of 
positive 
psychotic 
symptoms  
 
  
Treatment 
initiation 
Short DUP =     
< 30 days 
Medium DUP 
= 31-180 days 
Long DUP =     
> 180 days 
180  
days 
 
Clinical – 
Symptomatic 
Remission  
DUP longer than 30 
days adversely impacts 
the long-term outcome.    
             [Yes] 
Note: *DUP main focus; DUP = Duration of Untreated Psychosis; n = count; & = and; % = Percentage. 
(Continued) 
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Table 2.1: Summary of Studies (n =12) Examining the Relationship between DUP and Long-Term (> 10-years) Outcome in People with 
First-Episode Psychosis or First-Episode Schizophrenia. 
Study 
Authors 
(Year) 
Country 
 
Sample Source Length of 
Follow-up 
Sample 
Size at      
Follow-up 
Rate of 
Follow-up 
n/total (%) 
Measurement of DUP 
 
 
      Onset                     Endpoint 
DUP 
Categorization 
Mean 
DUP 
Outcome(s)/      
Outcome Measures 
 
Relationship between 
DUP & Outcome(s) 
[Yes/No] 
Austin        
et al. 
(2015) 
!
Denmark! OPUS trial; Inpatient 
& Outpatient Mental 
Health Services!
10 years! 304 People with 
First-Episode 
Psychosis !
304/496 
(61%)!
At least one 
psychotic 
symptom 
definitely 
present  
!
Initiation of 
treatment!
! 52 weeks 
(full; 
baseline 
sample)!
Positive and Negative 
Symptom Trajectories !
Longer DUP was 
associated with poorer 
positive symptom 
trajectories (i.e., 
higher levels of 
psychotic symptoms).     
              [Yes] 
Jaracz    et 
al. (2015) 
 
Poland Hospital  9 years+ 64 Patients 
Hospitalized for 
First-Episode 
Schizophrenia  
64/86                  
(74%) 
Appearance of 
the first 
psychotic 
symptoms  
 
First psychiatric 
hospitalization  
10.4 
months 
(baseline 
sample) 
Good Outcome = 
simultaneously 
meeting criteria for 
symptomatic and 
functional remissions, 
as well as satisfying 
quality of life 
Poor Outcome =      
Not meeting all of the 
criteria of a good 
outcome  
Longer DUP was 
significantly 
associated with poor 
outcome. 
[Yes] 
Rund    et 
al.  
(2015)* 
 
Norway & 
Denmark 
The Treatment 
&Intervention in 
Psychosis Study 
(TIPS); Specialist 
Psychiatric Health-
Care Services of four 
Scandinavian Health 
Care Sectors 
10 years 261 First-
Episode 
Psychosis 
Patients  
(Inpatients & 
outpatients)    
261/301 
(87%) 
PANSS score 
of 4 or more 
on one of the 
following 
items: P1, P3, 
P5, P6, or G9 
 
Antipsychotic 
medication or 
admission to the 
hospital for 
treatment of acute 
psychosis 
 11 weeks Neurocognition Absence of a 
significant association 
between DUP and the 
neurocognitive 
composite score. 
[No] 
Friis et al. 
(2016) 
Norway & 
Denmark 
The Treatment 
&Intervention in 
Psychosis Study 
(TIPS); Specialist 
Psychiatric Health-
Care Services of four 
Scandinavian Health 
Care Sectors 
10 years 186 Patients 
with Non-
Affective First-
Episode 
Psychosis 
(Inpatients & 
outpatients)    
186/301              
(62%) 
Psychosis 
onset = First 
appearance of 
being actively 
psychotic  
 
Start of the first 
adequate treatment  
of psychosis 
(antipsychotic 
medication or 
hospitalization) 
< 26 weeks 
> 26 weeks 
47.4 weeks Time in Psychosis; 
defined as time with 
scores >4 on any of 
the following  PANSS 
items: P1, P3, P5, P6, 
and G9 
DUP of > 26 weeks 
was significantly 
associated with longer 
time in psychosis 
during the 10-year 
follow-up period           
[ Yes] 
Note: *DUP main focus; DUP = Duration of Untreated Psychosis; n = count; + = Mean length of follow-up (7-11 years); PANSS = Positive and Negative Syndrome 
Scale; P = Positive Scale; G = General Scale; & = and; % = Percentage. 
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In the majority of the studies (n = 7), the duration of untreated psychosis was treated as a 
continuous variable, based on the assumption that the duration of untreated psychosis has 
a linear effect on outcomes (Tang et al., 2014), such that the likelihood of poor outcomes 
increases as the duration of untreated psychosis increases. In the remaining studies (n = 
5), the duration of untreated psychosis variable was categorized or dichotomized, based 
on the assumption that the duration of untreated psychosis has a threshold effect on 
outcomes (Singh, 2007; Tang et al., 2014), such that the duration of untreated psychosis 
will have no effect on outcomes unless a particular threshold value is reached or exceed. 
Once the threshold value of the duration of untreated psychosis is reached or exceeded, 
the likelihood of a poor outcome increases. Different cut-off values were used to classify 
the duration of untreated psychosis as “long.” For instance, Tang and colleagues (2014) 
defined “long” as greater than four-months, whereas Ichinose and colleagues (2010) 
defined “long” as greater than one-year.  
Overall, a majority of studies (n = 8) reported a statistically significant relationship 
between the duration of untreated psychosis and long-term outcomes (Austin et al., 2015; 
Friis et al., 2016; Hill et al., 2012; Jaracz et al., 2015; Ichinose et al., 2010; Kinoshita et 
al., 2005; Tang et al., 2014; White et al., 2009). Among the studies that kept the duration 
of untreated psychosis as a continuous variable (n = 7), a few of these studies (n = 4) 
reported that the longer the duration of untreated psychosis the poorer the outcome 
(Austin et al., 2015; Jaracz et al., 2015; Kinoshita et al., 2005; White et al., 2009). These 
outcomes included: 
•! Poorer positive symptom trajectories (Austin et al., 2015) 
•! Poor outcome (i.e., not meeting criteria for symptomatic and functional 
remissions, nor satisfying quality of life) (Jaracz et al., 2015)  
•! Higher outcome symptom burden (White et al., 2009) 
Kinoshita and colleagues (2005) reported that a long duration of untreated psychosis 
was significantly associated with poor outcome at 10-year follow-up, but not at 15-
year follow-up.  
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Among the studies that categorized or dichotomized the duration of untreated psychosis 
(n = 5), a majority of these studies (n = 4) reported that a longer duration of untreated 
psychosis was significantly associated with poorer outcomes (Friis et al., 2016; Hill et al., 
2012; Ichinose et al., 2010; Tang et al., 2014). These poorer outcomes included: 
•! Longer time in psychosis (Friis et al., 2016) 
•! Poorer remission status, greater severity of positive and negative symptoms, 
greater impairment in general functioning, social functioning, and quality of life 
(Hill et al., 2012) 
•! Decreased scores on the Global Assessment Schedule, Disability Assessment 
Schedule, and Clinical Global Impression (Ichinose et al., 2010) 
•! Poor symptomatic remission (Tang et al., 2014) 
2.1.3! Long DUP-Poor Outcome Link: Underlying Mechanism  
To date, the mechanism underlying the observed association between a long duration of 
untreated psychosis and poor short-term (< 10-years) or long-term (> 10-years) outcome 
in people with first-episode psychosis is not yet known (Chou et al., 2015; Marshall et al., 
2005; Perkins, Gu, Boteva, & Lieberman, 2005). The duration of untreated psychosis has 
been proposed to have a direct and/or indirect impact on outcomes because of its 
hypothesized neurotoxic and/or socially toxic effects (Norman, 2014; Wyatt, 1991) 
(Figure 2.2).  
 
Figure 2.2: A Visual Representation of the Hypothesized Neurotoxic and Socially 
Toxic Effects that a Long Duration of Untreated Psychosis has on Outcomes in 
People with First-Episode Psychosis. 
21 
 
Wyatt (1991) proposed that untreated psychosis is somehow neurotoxic because it results 
in potentially irreversible damage to the brain, with longer durations of untreated 
psychosis resulting in greater damage to the brain. Hypothesized mechanisms to explain 
this toxicity include dopaminergic (catecholaminergic) hyperactivity and prolonged 
hypothalamic-pituitary-adrenal activation (Andersen, Voineskos, Mulsant, Gerorge, & 
McKenzie, 2014). Evidence for the possible neurotoxic effects of untreated psychosis is 
inconclusive (Anderson et al., 2015; McGlashan, 2006; Rund, 2014). 
Recently, Norman (2014) proposed that a longer duration of untreated psychosis may 
have socially toxic effects, which mediate its impact on outcomes. He argues that a third 
variable, specifically a psychosocial factor such as social support, may mediate the 
relationship between duration of untreated psychosis and outcomes. For instance, a long 
duration of untreated psychosis could result in poor social support, poor social support in 
turn, could have an adverse impact on outcomes (Figure 2.2). Therefore, a long duration 
of untreated psychosis has an impact on outcomes indirectly through a third variable, 
poor social support. However, evidence for possible socially toxic effects is needed, with 
examination of the mediating role of different types of social support and other 
psychosocial factors (Norman, 2014).  
2.1.4! Long Term Outcome (> 10-years): Relapse  
Based on our literature search of studies examining the association between the duration 
of untreated psychosis and long-term (> 10-years) outcomes in people with first-episode 
psychosis or first-episode schizophrenia, no study to date has examined relapse as a long-
term outcome (Table 2.1).  
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2.2! Recovery  
2.2.1! Definition of Recovery  
The most influential definition of recovery was put forth by Anthony (Wallcraft, 2012): 
“Recovery is described as a deeply personal, unique process of changing one’s 
attitudes, values, feelings, goals, skills, and/or roles. It is a way of living a 
satisfying, hopeful, and contributing life even with limitations caused by illness. 
Recovery involves the development of new meaning and purpose in one’s life as 
one grows beyond the catastrophic effects of mental illness. Recovery from 
mental illness involves much more than recovery from the illness itself…” 
(Anthony, 1993). 
While this definition has not been widely accepted in its entirety, elements of this 
definition have been extracted by others in ongoing efforts to define recovery. Therefore, 
no standardized definition or set of criteria for recovery exists, which may it part be 
complicated by the multi-dimensional nature of this construct (Davidson, O’Connell, 
Tondora, Staehuli, & Evans, 2005; Harvey & Bellack, 2009; Liberman & Kopelowicz, 
2005; Silverstein & Bellack, 2008).  
2.2.2! Recovery Following a First Episode of Psychosis  
2.2.2.1! Variability in Recovery  
People can and do recover after a first episode of psychosis; however, considerable 
variability exists (de Koning et al., 2009; Lam et al., 2010; Marshall & Rathbone, 2011). 
Rates of recovery following a first episode of psychosis range between 14% (Austin et 
al., 2013) to 29.4% (Verma, Subramaniam, Abdin, Poon, & Chong, 2012) depending on 
how recovery was operationalized and the length of follow-up. Moreover, factors 
perceived to facilitate or hinder recovery and the signs of recovery may potentially 
contribute to the variability observed across people who have or have not recovered after 
a first episode of psychosis. Even among those who have recovered, variability exists in 
their recovery style. 
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Factors Perceived to Facilitate or Hinder Recovery  
From the perspective of people who have experienced a first episode of psychosis, there 
are a number of factors that either facilitate or hinder one’ chance of recovery. Factors 
perceived to facilitate recovery include social support, medication, having to care for 
someone, spirituality, lifestyle modification, meaningful activities, individual 
characteristics such as personal effort and hope, and interpersonal relationships with the 
professional team and members of a psychoeducation group (de Wet, Swartz, & Chiliza, 
2015; Eisenstadt, Monteiro, Diniz, & Chaves, 2012; Windell & Norman, 2012). Factors 
such as stigma, substance use, and adverse effects of medication are perceived to hinder 
recovery (de Wet, Swartz, & Chiliza, 2015; Eisenstadt, Monteiro, Diniz, & Chaves, 2012; 
Lam et al., 2010; Windell & Norman, 2012).  
Signs of Recovery  
The signs or meaning of recovery varies based on the person that is being asked, such as 
a clinician, family member, or the person who experienced a first episode of psychosis 
(Lam et al., 2010). Even among those who experienced a first episode of psychosis, the 
signs of recovery vary. Table 2.2 summarizes the signs of recovery as indicated by people 
who experienced a first episode of psychosis. As summarized in Table 2.2, there are a 
number of signs of recovery, each reflecting different domains of a person’s life, which 
suggests that recovery is multidimensional and that assessment of recovery should take 
into account a person’s functioning in different domains of his or her life.  
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Table 2.2: Signs of Recovery as Indicated by People who Experienced a First 
Episode of Psychosis. 
Note: Signs of recovery (overall themes) as reported by participants in qualitative 
interviews.  
We also noted that divergent views exist as to whether taking medication is a sign of 
recovery (Lam et al., 2010; Windell, Norman, & Malla, 2012). We further noted that 
elimination or reduction of symptoms (Eisenstadt, Monteiro, Diniz, & Chaves, 2012; 
Windell, Norman, & Malla, 2012) was found to be a common sign of recovery, which is 
generally the sign of recovery acknowledged by clinicians (Lam et al., 2010). However, 
for some, elimination or reduction of symptoms was not acknowledged to be a sign of 
recovery (Lam et al., 2010), which illustrates that the signs of recovery according to the 
clinician do not always align with those of the client. Therefore, it is important to 
incorporate the signs or meaning of recovery based on perspectives of both the clinician 
Study Sample Signs of Recovery                                                                                       
(Overall Themes) 
 
Lam et al., 
(2010) 
6 people treated for a first 
episode of psychosis at an 
early intervention program  
•! Regaining previous cognitive functions (e.g., being able to 
concentrate) 
•! Regaining previous social functions (e.g., engage with family and 
friends) 
•! Being normal 
•! No medication 
Eisenstadt et al.,     
(2012) 
16 people treated for a first 
episode of affective or non-
affective psychosis at an 
early intervention program  
•! Improvement in psychotic symptoms (decrease or absence) 
•! Changes in social relationships (e.g., return to social life) 
•! Renewed autonomy & independence (e.g., feel safe again to go out 
alone) 
•! Restoration of self-reliance & trust in others (i.e., trust themselves 
and others) 
Windell et al., 
(2012) 
30 people who received 
initial treatment for a first 
episode of psychosis at an 
early intervention service 3 
to 5-years ago 
•! Alleviation of symptoms, especially positive symptoms  
•! Subjective control over the extent and influence of symptoms, and 
reduction of distress associated with the symptoms 
•! Regaining a sense of control and a coherent sense of self (e.g., 
acceptance of illness) 
•! Engagement in meaningful activities (resume or engage in new work 
and/or school) 
•! Participation in social relationships (e.g., peer or romantic 
relationships) 
•! Taking medication 
•! Medication discontinuance 
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and the client allowing them to work towards a shared set of objectives to promote 
recovery (Ng et al., 2008).  
Recovery Style 
During the recovery phase of a first episode of psychosis (Figure 1.1), one of two 
recovery styles is adopted including integration or integrative versus sealing or seal over 
(Thompson, McGorry, & Harrigan, 2003). Those with an integrative recovery style 
incorporate their psychotic episode experience as part of their overall life experience and 
have a more optimistic outlook as he or she was able to learn new information about 
themselves (Thompson, McGorry, & Harrigan, 2003). In contrast, those with a sealing 
over recovery style tend to dissociate their psychotic episode experience from their 
overall life experience in an effort to protect themselves from the stigma associated with 
psychosis and to preserve their mental well-being (Thompson, McGorry, & Harrigan, 
2003). Furthermore, those with an integrative recovery style tend to be more compliant 
with treatment, whereas those with the latter recovery style deny that anything is wrong 
and resist treatment (McGlashan & Levy, 1997; Thompson, McGorry, & Harrigan, 
2003), which may explain why those with the former recovery style have better outcomes 
post-recovery than those with the latter recovery style (Thompson, McGorry, & Harrigan, 
2003). 
2.2.2.2! Relapse  
Views vary on whether vulnerability to relapse risk can impact recovery. These views 
include: (i) vulnerability of relapse risk does impede recovery; (ii) recovery is possible 
and attainable while acknowledging vulnerability to relapse risk; and (iii) recovery is 
possible and attainable again after experiencing a relapse (Windell, Norman, & Malla, 
2012). These varying views demonstrate that for some, recovery is an end-state whereas 
for others it is an ongoing process in which a person oscillates between recovery and 
relapse.   
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Risk Factors for Relapse 
The existing literature suggests that a number of factors are associated with an increased 
risk of relapse after a first episode of psychosis, and consequently a decreased chance of 
recovery or period of recovery. These include younger age (Hui et al., 2013), younger age 
at onset (< 24 years) (Stefanescu et al., 2013), single marital status (Stefanescu et al., 
2013), poor premorbid adjustment (Alvarez-Jimenez et al., 2012), schizophrenia 
diagnosis (Hui et al., 2013), schizophrenia load in the family (Stefanescu et al., 2013), 
comorbid diagnosis of substance abuse (Malla et al., 2008), persistent substance use 
disorder (Alvarez-Jimenez et al., 2012), cannabis use (Bergé et al., 2015), smoking (Hui 
et al., 2013), shorter baseline hospitalization (Stefanescu et al., 2013), carer’s critical 
comments (Alvarez-Jimenez et al., 2012), poor insight (Bergé et al., 2015), and 
medication non-adherence (Alvarez-Jimenez et al., 2012; Hui et al., 2013). Factors 
identified to be associated with an early relapse after a first episode of psychosis include 
longer first hospitalization, higher severity of negative symptoms at onset, and a longer 
duration of untreated psychosis (Stefanescu et al., 2013).  
2.2.3! Empirical Study of Recovery: Recovery Models  
The definition, conceptualization, and assessment of recovery has generally been based 
on the traditional medical model of recovery or the more recent consumer model of 
recovery (Ahmed, Birgenheir, Buckley, & Mabe, 2013; Roe, Mashiach-Eizenberg, & 
Lysaker, 2011). The former model is based on the definition of recovery in the scientific 
literature and reflects the perspective of the clinician, researcher, or service provider, 
while the latter model is based on the definition of recovery in the consumer and 
rehabilitation literatures and reflects the patient, service user, or client’s own perspective. 
In the traditional model, recovery is conceptualized as an outcome or endpoint and it is 
defined as the elimination or reduction of psychotic symptoms and return to pre-illness 
levels of function for a certain period of time (Bellack, 2006; Liberman & Kopelowicz, 
2005). In the more recent model, recovery is conceptualized as an ongoing process that is 
subjective, unique, person-centered (Davidson, O’Connell, Tondora, Staehuli, & Evans, 
2005; Silverstein & Bellack, 2008), and it is defined by the person. Therefore, recovery 
can be conceptualized as either an outcome or as a process.  
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Both models each represent one of the two broad dimensions of recovery: (i) objective 
and (ii) subjective (Lysaker, Taylor, Miller, Beattie, Strasburger, & Davis, 2006), with 
the former dimension represented by the traditional model and the latter dimension 
represented by the newer model (Roe, Mashiach-Eizenberg, & Lysaker, 2011). The 
objective and subjective dimensions of recovery are often referred to as objective 
recovery and subjective recovery, respectively. In this thesis, we used the terms 
subjective recovery and self-perceived recovery interchangeably. A list of other 
synonyms for the term subjective recovery is provided in Appendix A.  
2.2.4! Assessment of Recovery as an Outcome  
The increased interest in the assessment of recovery as an outcome may perhaps be 
attributed to the potential of improving recovery-oriented services directed to promote 
and/or sustain recovery following a first episode of psychosis (Drake, Noel, & Deegan, 
2015). 
2.2.4.1! Objective Recovery  
The assessment of objective recovery in the past has generally been based on the 
reduction or elimination of symptoms (Addington, Young, & Addington, 2003; Resnick, 
Rosenheck, & Lehman, 2004). More recently, it has been acknowledged that other 
objective indicators (or measures) of recovery, aside from or in conjunction with 
symptomatic outcomes, need to be taken into account, such as social, functional, or 
vocational outcomes (Gee et al., 2016; Kam, Singh, & Upthegrove, 2015; Major et al., 
2010). One such indicator that is increasingly being used is engagement in meaningful 
activities such as work and/or school, which is often referred to as vocational outcomes, 
vocational activity, or occupational activity (Major et al., 2010; Norman et al., 2007; 
Norman et al., 2012). We chose to use occupational activity as an indicator of objective 
recovery, defined as engagement in work and/or school on a full-time or part-time basis 
in the past year.  
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2.2.4.2! Subjective Recovery  
The assessment of subjective recovery in the past has focused on the process, experience, 
or meaning of recovery based on first-person accounts of those with first-episode 
psychosis (e.g., Connell, Schweitzerder, & King, 2015; de Wet, Swartz, & Chiliza, 2015; 
Windell & Norman, 2012; Windell, Norman, & Malla, 2012). The shift towards the 
assessment of subjective recovery as an outcome is a relatively new phenomenon, which 
can be attested to by the relatively few studies that currently exist in the literature (Law, 
Shryane, Bentall, & Morrison, 2015; Morland, 2007; Morrison et al., 2013; Norman, 
Windell, Lynch, & Manchanda, 2013) (Table 2.3).  
Among the few (n = 4), mostly cross-sectional studies (n = 3) that did assess subjective 
recovery as an outcome, albeit with different subjective recovery measures, findings from 
these studies suggest that people with first-episode psychosis or experience with 
psychosis are more likely to report higher levels of subjective recovery when 
experiencing lower levels of the following: 
•! Anxiety and depression (Morland, 2007) 
•! Negative emotion (Morrison et al., 2013; Law, Shryane, Bentall, & Morrison, 
2015) 
•! Hopelessness (Law, Shryane, Bentall, & Morrison, 2015) 
•! Positive and negative symptoms (Norman, Windell, Lynch, & Manchanda, 2013) 
also when experiencing higher levels of the following: 
•! Internal locus of control (Morrison et al., 2013)  
•! Perceived relational evaluation (Norman, Windell, Lynch, & Manchanda, 2013) 
•! Positive self-esteem (Law, Shryane, Bentall, & Morrison, 2015) (Table 2.3) 
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Table 2.3: Studies (n = 4) Assessing Subjective Recovery as an Outcome in People with First-Episode Psychosis or Experience 
with Psychosis. 
Study Study 
Design 
Sample Source 
(n) 
Sample Size Variables of Interest 
(Measure) 
Subjective 
Recovery 
Outcome 
Measure 
Findings  
Morland  
(2007) 
Cross-
Sectional 
Stand-alone’ Early 
Intervention Service 
team (n = 54) or 
‘Augmented’ 
Community Mental 
Health Team (n = 6) 
60 people 
with first-
episode 
psychosis 
 
i) General psychopathology 
symptoms of anxiety & 
depression 
ii) Positive symptoms 
(hallucinations & delusions)      
iii) Negative symptoms                                      
iv) Engagement in paid 
employment or education 
v) Gender 
vi) Age (years) at the time of 
interview 
vii) Length of time (months) 
in service 
Mental Health 
Recovery Scale 
(MHRS) 
-Significant negative association between anxiety and 
subjective recovery. 
 
-Significant negative association between depression 
and subjective recovery. 
 
-No significant association between subjective 
recovery and the other factors of interest. 
Morrison 
et al. 
(2013)!
Cross-
Sectional !
Early intervention 
services (n = 40), 
other community-
based mental health 
teams (n = 81), & an 
inpatient unit (n = 
1).!
122 people 
with 
experience of 
psychosis  
 
!
Psychosocial:  
Self-esteem, locus of control, 
& emotion 
Neuropsychiatric: 
Psychotic symptoms, 
neurocognition, & insight 
!
Questionnaire 
Process of 
Recovery (QPR) 
& Recovery 
Analogue Scale  
(RecA)!
-Findings from structural equation modeling indicated 
that self-rated recovery from psychosis was directly 
influenced by negative emotion (i.e., anxiety, 
depression, and negative self-esteem) and internal 
locus of control.!
Note: n = count; & = and; PEPP = Prevention and Early Intervention Program for Psychosis; MHRS = Mental Health Recovery Scale; RAS = Recovery 
Assessment Scale; MES= Modified Engulfment Scale; QPR = Questionnaire Process of Recovery; RecA = Recovery Analogue Scale.                        
                                                                                                                                                                                                                                              (Continued) 
30 
 
Table 2.3: Studies (n = 4) Assessing Subjective Recovery as an Outcome in People with First-Episode Psychosis or Experience 
with Psychosis.  
 
Note: n = count; & = and; QPR = Questionnaire Process of Recovery; SAPS = Scale for the Assessment of Positive Symptoms; SANS = Scale for the 
Assessment of Negative Symptoms; ISEL = Interpersonal Support Evaluation List; PRES = Perceived Relational Evaluation Scale.                                                          
Study Study 
Design 
Sample Source 
(n) 
Sample Size Variables of Interest 
(Measure) 
Subjective 
Recovery 
Outcome 
Measure 
Findings 
Norrman  
et al. 
(2013)!
Cross-
Sectional!
Early Intervention 
Program (PEPP)!
84 people 
receiving 
treatment for 
a first-
episode of 
psychosis !
i) Positive Symptoms 
(SAPS) 
ii) Negative Symptoms  
(SANS) 
iii) Social Support (ISEL & 
PRES) 
!
Recovery 
Assessment 
Scale (RAS) 
& Modified 
Engulfment 
Scale (MES)!
-Significant negative association between positive 
symptoms and two or more of the five subscales of the 
Recovery Assessment Scale. 
 
- Significant negative association between negative 
symptoms and two or more of the five subscales of the 
Recovery Assessment Scale. 
 
- Significant positive association between PRES with the 
MES, and with each of the subscales of the RAS and 
MES. !
Law et al. 
(2015) 
Longitudinal 
(6-months) 
Early intervention 
services (n = 27), 
community-based 
mental health teams 
(n = 45), in-patient 
service (n = 1). 
Unknown referral 
type (n = 37) 
110 people 
with 
experience 
of psychosis  
 
Negative emotion, 
Psychiatric symptoms, 
Hopelessness,  
Positive self-esteem, and  
Functioning 
Questionnaire 
Process of 
Recovery 
(QPR) 
-Finding from path analysis indicated that subjective 
recovery at 6-months follow-up was negatively 
associated with both negative emotion (baseline) and 
hopelessness (baseline), and positively associated with 
positive self-esteem (baseline). 
 
-Subjective recovery at 6-months follow-up was 
negatively associated with psychiatric symptoms 
(baseline) and positively associated with functioning 
(baseline); however, these associations with subjective 
recovery were not as strong as the associations between 
the other factors of interest. 
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Comparability of findings of these and future studies assessing subjective recovery as an 
outcome is precluded by the lack of a universal gold standard measure. A recent review of 
existing subjective recovery measures identified a total of 13 such measures (Shank et al., 2013). 
The Maryland Assessment of Recovery in People with Serious Mental Illness Scale (MARS) 
(Bellack & Drapalski, 2012) was among the 13 measures identified in the review, which is the 
measure used in the current study to assess subjective recovery. The MARS is unique as a 
recovery measure because it is the only measure to assess recovery using the Substance Abuse 
Mental Health Services Administration (SAMHSA) operational definition of recovery (Ahmed, 
Birgenheir, Buckley, & Mabe, 2013) that states:  
“Mental health recovery is a journey of healing and transformation enabling a person 
with a mental disability to live a meaningful life in the community of his or her choice 
while striving to achieve full human potential or personhood.” (SAMHSA, p.1). 
2.2.5! Comprehensive Assessment of Recovery  
The relationship between objective and subjective recovery from a first episode of psychosis or 
from a psychotic disorder (e.g., schizophrenia) has been examined by several empirical studies 
(Jørgensen et al., 2015; Kukla, Lysaker, & Roe, 2014; Lloyd, King, & Moore, 2010; Morland, 
2007; Norman, Windell, Lynch & Manchanda, 2013; Resnick, Rosenheck, & Lehman, 2004; 
Roe, Mashiach-Eizenberg & Lysaker, 2011). However, findings from these studies have been 
inconclusive. Given that there is some evidence suggesting an absence of an association 
(Jørgensen et al., 2015; Lloyd, King, & Moore, 2010; Morland, 2007; Norman, Windell, Lynch, 
& Manchanda, 2013; Resnick, Rosenheck, & Lehman, 2004), assessment of a person’s recovery 
would not be comprehensive and potentially inaccurate if both objective and subjective recovery 
are not taken into account. We therefore decided to include both objective and subjective 
recovery as outcomes in this thesis.  
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2.3! DUP & Recovery: Existing Literature 
The duration of untreated psychosis is one of the few most widely studied modifiable risk factors 
of poor outcome in people with first-episode psychosis (e.g., Compton et al., 2007; Tang et al., 
2014). With growing research and clinical interest in recovery as an outcome, the impact of the 
duration of untreated psychosis on recovery following a first episode psychosis has increasingly 
come into focus in recent years.  
Our existing knowledge of the association between the duration of untreated psychosis and 
recovery has mainly been based on studies with follow-up periods of less than 10-years, and 
those conducted in countries other than Canada (Table 2.4). The duration of untreated psychosis 
has been reported to be negatively associated with objective recovery (Chang 2012b; Verma, 
Subramaniam, Abdin, Poon, & Chong, 2012), and with specific types of objective recovery 
including clinical recovery (Chang et al., 2012a; Faber at al., 2011; Winderink, Sytema, 
Nienhuis, & Wiersma, 2009), vocational recovery (Major et al., 2010) and psychiatric recovery 
(Gumley et al., 2014) (Table 2.4). Interestingly, across different studies, both a shorter and 
longer (> 3-months) duration of untreated psychosis has been reported to be negatively 
associated with objective recovery, specifically clinical recovery (Chang et al., 2012a; Chang et 
al., 2012b) at 3-year follow-up (Table 2.4).  
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Table 2.4: Summary of Studies (n = 9) Investigating the Association between DUP and Recovery. 
Study 
Authors 
     (Year)!
Country! Sample 
Source!
Length of 
Follow-up!
Sample 
Size at 
Follow-
up!
Follow-up 
Rate 
n/total  (%)!
     Measurement of DUP 
 
 
 
                                          
    Onset                 Endpoint!
Mean 
DUP 
!
Recovery  
Dimension 
[Objective/ 
Subjective] 
!
Operational Criteria for 
Recovery!
Recovery 
Rate 
 n/total; %!
Presence of an 
Association 
between DUP  
& Recovery 
[Yes/No]!
Wunderink  
et al. 
(2009)**!
Netherlands! MESIFOS 
(Medication 
Strategies In 
First Onset 
Schizophrenia) 
study; Seven 
Mental Health 
Services!
Last 9-
months of 
2-year 
period!
125 
Patients 
with 
First-
Episode 
Psychosis 
!
125/257 
(49%)!
First 
manifestation 
of any 
positive 
psychotic 
symptom!
Start of 
antipsychotic 
treatment!
Recovered 
= 31.8 days 
 
Non-
recovered = 
320.9 days!
Clinical 
[Objective]!
Symptomatic & Functional 
Remission 
 Symptomatic Remission: 
Exacerbation of symptoms for 
at least 1 week with at least one 
relevant PANSS item score 
above 3 (mild):P1 (delusions), 
P2 (conceptual disorganization), 
P3 (hallucinatory behavior), N1 
(blunted affect), N4 (social 
withdrawal), N6 (lack of 
spontaneity), G5 
(mannerisms/posturing), and G9 
(unusual thought content).  
Functional Remission: A patient 
should function adequately in 
all 7 social roles with none or 
only a minimal disability in any 
of them (not allowing a score of 
2 or 3 on any GSDS role).!
24/125; 
19.2% 
(End of 2-
year follow -
up period)!
Presence of a 
statistically 
significant 
association 
between DUP 
and clinical 
recovery. 
     [Yes] 
   
 
Major et al.       
(2010)!
London! Early 
Intervention 
Service !
1 year! 114 
Service 
Users 
with 
First-
Episode 
Psychosis!
114/129 
(88%)!
Emergence 
of the first 
positive 
psychotic 
symptom!
Initiation of 
treatment !
86 days 
(median)!
Vocational 
[Objective]!
Gaining or returning to 
competitive employment 
(competitively accessed work, 
paid at the market rate) or an 
educational activity which 
clearly led to a nationally 
recognized vocational 
qualification or degree, entered 
into at any point in the follow-
up period and for any duration.!
Not 
Specified!
Absence of a 
statistically 
significant 
association 
between DUP 
and vocational 
recovery during 
1-year follow-up.  
     [No]  
!
Note: ** Recovery was assessed before the end of the follow-up period; DUP = Duration of Untreated Psychosis; n = count; GSDS = Groningen Social Disabilities Schedule; PANSS = Positive and Negative Syndrome Scale;         
P = Positive Scale; N = Negative Scale; G = General Psychopathology Scale; & = and; % = Percentage.                                                                                                                                                                                     (Continued)                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                   
!
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Table 2.4: Summary of Studies (n = 9) Investigating the Association between DUP and Recovery. 
Study 
Authors 
     (Year)!
Country! Sample 
Source!
Length of 
Follow-up!
Sample 
Size at 
Follow-
up!
Follow-up 
Rate 
n/total  (%)!
     Measurement of DUP 
 
 
 
                                          
    Onset                 Endpoint!
Mean 
DUP 
!
Recovery  
Dimension 
[Objective/ 
Subjective] 
!
Operational Criteria for 
Recovery!
Recovery 
Rate 
   n/total; % 
Presence of an 
Association 
between DUP  
& Recovery    
    [Yes/No]!
Albert et al. 
(2011)!
!
Denmark! OPUS trial; 
Inpatient & 
Outpatient 
Mental Health 
Services!
5 years! 255 
Patients 
with 
First-
Episode 
Non-
Affective 
Psychosis!
255/468 
(54%)!
Not  
Specified!
Onset of 
adequate 
treatment!
Recovered 
= 92 weeks 
 
Non-
Recovered 
= 121 
weeks!
Not 
Specified 
[Objective]!
Recovery was defined as 
working or studying, having a 
GAF-function score of 60 or 
above, having remission of 
negative and psychotic 
symptoms, and not living in a 
supported housing facility or 
being hospitalized during the 
last 2 years.!
40/255; 
15.7%!
!
Absence of a 
statistically 
significant 
association 
between DUP 
and recovery at 
5-year follow-
up. 
       [No]!!
Faber et al.  
(2011)!
Netherlands! Add onto 
MESIFOS 
(Medication 
Strategies In 
First Onset 
Schizophrenia) 
study; Seven 
Mental Health 
Services for 
Psychosis!
2 years! 45 
Patients   
with 
Non-
Affective 
First-
Episode 
Psychosis!
45/125 
(36%)!
First 
manifestation 
of any 
positive 
psychotic 
symptom!
Start of 
antipsychotic 
treatment!
Recovered 
= 34 days 
 
Non-
recovered = 
294 days 
Clinical 
[Objective]!
Symptomatic & Functional 
Remission 
Symptomatic Remission:     
An exacerbation of symptoms 
for at least 1 week with at 
least one relevant PANSS 
item score above 3 (mild):P1 
(delusions), P2 (conceptual 
disorganization), P3 
(hallucinatory behavior), N1 
(blunted affect), N4 (social 
withdrawal), N6 (lack of 
spontaneity), G5 
(mannerisms/posturing), and 
G9 (unusual thought content).  
Functional Remission: 
Function adequately in all 
social roles (Self-care, 
Housekeeping, Family 
relationships, Partner 
relationships, Community 
integration, Relationship with 
peers, Vocational role & 
Parental role) with none or 
only a minimal disability in 
any of them (not allowing a 
score of 2 or 3 on any GSDS 
role).!
9/45; 
20% 
!
Presence of a 
statistically 
significant 
association 
between DUP 
and clinical 
recovery. 
    [Yes] !
Note: DUP = Duration of Untreated Psychosis; n = count; GSDS = Groningen Social Disabilities Schedule; GAF-F = Global Assessment of Functioning-Functioning Scale; PANSS = Positive and Negative Syndrome Scale; P = 
Positive Scale; N = Negative Scale; G = General Psychopathology Scale; & = and; % = Percentage.                                                                                                                                                                                           (Continued)                                                                         !
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 Table 2.4: Summary of Studies (n = 9) Investigating the Association between DUP and Recovery. 
Study 
Authors 
     (Year)!
Country! Sample 
Source!
Length of 
Follow-up!
Sample 
Size at 
Follow-
up!
Follow-up 
Rate 
n/total  (%)!
     Measurement of DUP 
 
 
 
                                          
    Onset                 Endpoint!
Mean 
DUP 
!
Recovery  
Dimension 
[Objective/ 
Subjective] 
!
Operational Criteria for Recovery! Recovery 
Rate  
n/total; %    
Presence of an 
Association 
between DUP  
& Recovery 
[Yes/No]!
Chang et al. 
(2012a)!
Hong Kong! EASY 
programme 
(Early 
Assessment 
Service for 
Young People 
with 
Psychosis); 
Early 
Intervention 
Program!
3 years! 539 
Chinese 
people 
with 
First-
Episode 
Psychosis!
539/700 
(77%)!
Onset of 
positive 
psychotic 
symptoms!
First 
contact 
with the 
psychiatric 
service 
(EASY 
progr-
amme)!
226.3 days! Clinical 
[Objective]!
Symptomatic & Functional 
Remission 
Recovery: Simultaneous fulfillment 
of the following criteria in the last 12 
months of study period: (i) CGI-S 
scores < 3 for both positive and 
negative symptoms; (ii) no 
psychiatric admission; (iii) achieving 
functional remission. Functional 
remission was defined as attaining 
both sustained employment (full-
time or part-time work/study) and 
SOFAS score > 60 in the last 12 
months of the follow-up period.!
94/539; 
17.4%!
Presence of a 
statistically 
significant 
association 
between shorter 
DUP (< 3 
months) and 
recovery. 
     [Yes]!
Chang et al. 
(2012b)!
Hong Kong! EASY 
programme; 
Early 
Intervention 
Program!
3 years! 700 
Chinese 
people 
with 
First-
Episode 
Psychosis!
700/839      
(83%)!
Onset of 
positive 
psychotic 
symptoms!
First 
contact to 
psychiatric 
service!
DUP < 3 
months = 
30.1 days 
(n = 346) 
 
DUP >3 
months = 
444.8 days    
(n = 354) 
Not 
Specified 
[Objective]!
Symptom Remission & 
Full-Time Employment Status 
Recovery: Maintaining CGI-S scores 
<3 for both positive and negative 
symptoms and full-time employment 
status for at least 12 consecutive 
months after treatment initiation. !
Not  
Specified!
Presence of a 
statistically 
significant 
association 
between long 
DUP (> 3 
months) and 
recovery. 
     [Yes] 
 !
Verma et al., 
(2012) 
Singapore Early 
Psychosis 
Intervention 
Programme 
2 years 1175 
Patients 
with 
First- 
Episode 
Psychosis 
1175/1718 
(68%) 
Onset of 
psychotic 
symptoms 
(delusions, 
hallucinations, 
disorganized 
behavior) 
Definitive 
diagnosis 
and 
treatment 
established 
16.2 
months 
Not 
Specified 
[Objective] 
Symptomatic & Functional 
Remission 
Recovery: Meeting criteria for both 
symptomatic & functional remission; 
Criteria for symptomatic remission 
as proposed by the Schizophrenia 
Working Group, that is, 
achieving……(continued) !
345/1175; 
29.4% 
Presence of a 
statistically 
significant 
association 
between shorter 
DUP and 
recovery at 2-
year follow-up. 
     [Yes] 
Note: DUP = Duration of Untreated Psychosis; n = count; CGI-S = Clinical Global Impression-Severity of Illness Scale; SOFAS = Social Occupational Functioning Assessment Scale; EASY = Early Assessment Service for Young 
People with Psychosis; & = and; % = Percentage.                                                                                                                                                                                                                                                                             (Continued)!
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Table 2.4: Summary of Studies (n = 9) Investigating the Association between DUP and Recovery. 
Study 
Authors 
     (Year)!
Country! Sample 
Source!
Length of 
Follow-up!
Sample 
Size at 
Follow-
up!
Follow-up 
Rate 
n/total  (%)!
     Measurement of DUP 
 
 
 
                                          
    Onset                 Endpoint!
Mean 
DUP 
!
Recovery  
Dimension 
[Objective/ 
Subjective] 
!
Operational Criteria for 
Recovery!
Recovery 
Rate 
  n/total; % 
Presence of an 
Association  
between DUP  
& Recovery 
[Yes/No]!
 
 
 
(Continued)!
 
 
 
--!
 
 
 
--!
 
 
 
--!
 
 
 
--!
 
 
 
--!
 
 
 
--!
 
 
 
--!
 
 
 
--!
 
 
 
--!
and maintaining a PANSS rating 
of three or less for a duration of 
at least 6-months on the 
following items: Delusions (P1), 
unusual thought contents (G9), 
hallucinatory behaviour (P3), 
conceptual disorganization (P2), 
mannerisms (G5), blunted affect 
(N1), social withdrawal (N4) and 
lack of spontaneity (N6) (7). 
Functional remission was defined 
as having a GAF disability score 
of >61 with engagement in age- 
appropriate vocation (gainfully 
employed or studying) at 2 years.!
 
 
 
--!
 
 
 
--!
Austin et al. 
(2013)* 
!
Denmark! OPUS trial; 
Inpatient & 
Outpatient 
Mental Health 
Services!
10 years! 304 
People 
with 
First-
Episode 
Psychosis!
304/496 
(61%)!
Not 
Specified!
Not  
Specified!
Recovered 
= 30.79 
weeks 
(median) 
 
Non-
recovered = 
50.43 
weeks          
(median) 
 
Not 
Specified 
[Objective]!
Full Recovery = Stable remission 
of both negative and positive 
symptoms, no psychiatric 
admissions to hospital or living 
in supported accommodation for 
the past two years, currently 
engaged in work or study and a 
GAF-F score of over 60 
(Liberman & Kopelowicz, 2005).  
 
Functional Recovery = Currently 
engaged in work/study, a GAF-F 
score over 60, and no psychiatric 
hospitalizations or living in 
supported accommodation for the 
past two years (Albert et al., 
2011) !
14% fully 
recovered 
 
60/304; 
20% 
functionally 
recovered!
Absence of a 
statistically 
significant 
association 
between DUP 
and recovery.  
       [No]!
Note: * Length of follow-up was 10 years or more. DUP = Duration of Untreated Psychosis; n = count; GAF = Global Assessment of Functioning Scale; GAF-F = Global Assessment of Functioning-Functioning Scale; PANSS = 
Positive and Negative Syndrome Scale; P = Positive Scale; N = Negative Scale; G = General Psychopathology Scale; & = and; % = Percentage.                                                                                                                       (Continued)                                                                                         !
37 
 
Table 2.4: Summary of Studies (n = 9) Investigating the Association between DUP and Recovery. 
Study 
Authors 
     (Year)!
Country! Sample 
Source!
Length of 
Follow-up!
Sample 
Size at 
Follow-
up!
Follow-up 
Rate 
n/total  (%)!
        Measurement of DUP 
 
 
 
                                          
    Onset                        Endpoint!
Mean 
DUP 
!
Recovery  
Dimension 
[Objective/ 
Subjective] 
!
Operational Criteria for 
Recovery!
Recovery 
Rate 
   n/total; % 
Presence of an 
Association 
between DUP  
& Recovery 
[Yes/No]!
Gumley et al. 
(2014)!
United 
Kingdom!
National 
Health Service 
(NHS) Mental 
Health Services!
1 year! 68 
People 
with 
First-
Episode 
Psychosis!
68/79 
(86%)!
Onset of 
 psychotic 
symptomatology!
Onset of 
treatment!
44.37 weeks! Psychiatric 
[Objective]!
Positive & Negative 
Symptoms  
!
Not 
Specified!
Presence of a 
statistically 
significant 
association 
between DUP 
and psychiatric 
recovery at 1-
year follow-up. 
     [Yes]!
Note: DUP = Duration of Untreated Psychosis; n = count; & = and; % = Percentage.!
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Our understanding of the relationship between the duration of untreated psychosis and the 
other dimension of recovery, subjective recovery, is limited because no study to date has 
examined the association between these two variables among people with a first episode 
of psychosis (Tables 2.3 & 2.4).  
2.4! Knowledge Gaps in Existing Literature 
The duration of untreated psychosis appears to be a widely studied modifiable risk factor 
of poor outcome in people with first-episode psychosis. It has been a target of early 
intervention programs because of evidence that shortening the duration of untreated 
psychosis consequently results in better outcomes. However, whether these beneficial 
gains are sustained over the long-term is not well known because of the limited number 
of prospective studies with follow-up periods of ten years or more.   
With recovery emerging as an outcome of interest, the association between the duration 
of untreated psychosis and recovery, specifically objective recovery, has increasingly 
been examined. However, no study to date has examined the association between the 
duration of untreated psychosis and subjective recovery.  
Furthermore, all studies to date that have examined the association between duration of 
untreated psychosis and long-term outcomes (>10-years) including recovery have been 
conducted in countries outside of Canada. 
2.5! Conceptual Framework 
We constructed a conceptual framework (Figure 2.3) to help visualize the relationships 
among the variables and to help identify which variables to treat as potential confounding 
variables in our pre-planned multivariable regression analyses. The inter-relationships 
between each of the variables in the context of people with first-episode psychosis are 
described below and are depicted within the conceptual framework. 
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Figure 2.3: Conceptual Framework. Visual Depiction of the Relationships between the Exposure, Outcomes, and Potential 
Confounding Variables. Note: Self-Perceived Recovery = Self-Perceived Recovery Score. 
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Exposure 
Duration of Untreated Psychosis  
A long duration of untreated psychosis has been reported to be associated with an 
increased risk for relapse (Stefanescu, Macrea, Popescu, Ilies, & Miclutia, 2013), an 
earlier age of onset (Ehmann et al., 2014), an insidious mode of onset (Compton, Chien, 
Leiner, Gouldstring, & Weiss, 2008; Morgan et al., 2006), poor premorbid adjustment 
(Bechard-Evans, Schmitz, Abadi, Joober, King, & Mallla, 2007; Schimmelmann, Huber, 
Lambert, Cotton, McGorry, & Conus, 2008), schizophrenia-spectrum diagnosis 
(Bechard-Evans, Schmitz, Abadi, Joober, King, & Mallla, 2007), poor social support 
(Comptom & Broussard, 2011), and greater positive and negative symptom severity (Hill 
et al., 2012). Furthermore, a long duration of untreated psychosis may result from the 
misattribution of positive symptoms of psychosis to the experience of ‘being high.’ 
Outcomes  
Occupational Activity  
Employment had been found to be a protective factor for relapse (Sariah, Outwater, & 
Malima, 2014). In addition, engagement in paid employment or education, both activities 
that hold social status can contribute to a greater sense of one’s self-perceived recovery 
(Windell & Norman, 2012). Furthermore, increased engagement in occupational activity 
has been reported to be associated with social support (Norman et al., 2007).  
Unemployment and/or lower educational level has been reported to be associated with 
drug use (Mishra, Ojha, Chapagain, & Tulachan, 2014), increased risk for relapse 
(Chabungbam, Avasthi, & Sharan, 2007), and medication non-adherence (Leclerc, Noto, 
Bressan, & Brietzke, 2015). 
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Potential Mediator  
Relapse  
A higher risk for relapse has been found to be associated with a long duration of 
untreated psychosis (Stefanescu, Macrea, Popescu, Ilies, & Miclutia, 2013), medication 
non-adherence (Alvarez-Jimenez et al., 2012), poorer premorbid adjustment (Alvarez-
Jimenez et al., 2012), schizophrenia-spectrum diagnosis (Hui et al., 2013), unemployment 
(Chabungbam, Avasthi, & Sharan, 2007), drug use (Bergé et al., 2015; Hui et al., 2013; 
Wade, Harrigan, Edwards, Burgess, Whelan, & McGorry, 2006), early age of onset 
(Stefanescu, Macrea, Popescu, Ilies, & Miclutia, 2013), single marital status (Stefanescu, 
Macrea, Popescu, Ilies, & Miclutia, 2013), and lower self-perceived recovery (Windell, 
Norman, & Malla, 2012). A decreased risk of relapse has been found to be associated 
with social support (Norman et al., 2005). In addition, males have been reported to have 
higher relapse rates than females (Ochoa, Usall, Cobo, Labad, & Kulkarni, 2012). 
Potential Confounding Variables 
Gender  
As compared to females, males tend to have an earlier age of onset (Ochoa, Usall, Cobo, 
Labad, & Kulkarni, 2012), greater drug use (Arranz et al., 2015), exhibit more negative 
symptoms (Køster, Lajer, Lindhardt, & Rosenbaum, 2008; Thorup et al., 2014), are less 
likely to be engaged in education (Thorup et al., 2014), are less compliant with 
medication (Køster, Lajer, Lindhardt, & Rosenbaum, 2008; Thorup et al., 2014), have 
higher relapse rates (Ochoa, Usall, Cobo, Labad, & Kulkarni, 2012), and poorer 
premorbid adjustment (Ochoa, Usall, Cobo, Labad, & Kulkarni, 2012).  
Age of Onset 
An earlier age of onset has been shown to be associated with being male (Ochoa, Usall, 
Cobo, Labad, & Kulkarni, 2012), medication non-adherence (Coldham, Addington, & 
Addington, 2002), a long duration of untreated psychosis (Ehmann et al., 2014), 
42 
 
increased risk for relapse (Stefanescu, Macrea, Popescu, Ilies, & Miclutia, 2013), and 
drug use. (Tosato et al., 2013) 
Mode of Onset  
An insidious mode of onset has been reported to be associated with a long duration of 
untreated psychosis (Compton, Chien, Leiner, Gouldstring, & Weiss, 2008; Morgan et 
al., 2006). 
Premorbid Adjustment 
Poor premorbid adjustment has been reported to be associated with a long duration of 
untreated psychosis (Bechard-Evans, Schmitz, Abadi, Joober, King, & Malla, 2007; 
Schimmelmann, Huber, Lambert, Cotton, McGorry, & Conus, 2008), being male (Ochoa, 
Usall, Cobo, Labad, & Kulkarni, 2012), medication non-adherence (Coldham, 
Addington, & Addington, 2002), and increased risk for relapse (Alvarez-Jimenez et al., 
2012).  In addition, poor premorbid adjustment has been identified as an early sign of 
schizophrenia (Gureje, Aderibigbe, Olley, & Bamidele, 1994; Schmael et al., 2007).  
Diagnosis of Schizophrenia-Spectrum  
A diagnosis of schizophrenia-spectrum has been reported to be associated with a long 
duration of untreated psychosis (Bechard-Evans, Schmitz, Abadi, Joober, King, & Malla, 
2007), an increased risk for relapse (Hui et al., 2013), greater likelihood of discontinued 
use of antipsychotic medication compared to people diagnosed with another type of first-
episode psychotic disorder (Hui et al., 2013). An early sign of schizophrenia is poor 
premorbid adjustment (Gureje, Aderibigbe, Olley, & Bamidele, 1994; Schmael et al., 
2007). 
Positive Symptoms 
Greater positive symptom severity has been shown to be associated with a long duration 
of untreated psychosis (Hill et al., 2012). It has also been reported that alleviation or 
elimination of symptoms contribute to a greater sense of self-perceived recovery 
(Windell & Norman, 2012; Windell, Norman, & Malla, 2012). 
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Negative Symptoms 
Greater negative symptom severity has been shown to be associated with a long duration 
of untreated psychosis (Hill et al., 2012). Furthermore, males tend to exhibit more 
negative symptoms than females (Køster, Lajer, Lindhardt, & Rosenbaum, 2008; Thorup 
et al., 2014). It has also been reported that alleviation or elimination of symptoms 
contribute to a greater sense of self-perceived recovery (Windell & Norman, 2012; 
Windell, Norman, & Malla, 2012).  
Socioeconomic Status 
The education variable in the conceptual framework refers to highest level of education, 
which was used as a proxy measure for socioeconomic status. Males are less likely than 
females to be engaged in education (Thorup et al., 2014), which in turn can diminish their 
ability to attain a well-paying job, generally speaking. A lower socioeconomic status may 
also diminish one’s sense of self-perceived recovery because of the difficulty in engaging 
in meaningful activities or achieving goals due to limited funds.  
Medication Non-Adherence  
Medication non-adherence has been reported to be associated with drug use (Miller, 
Ream, McCormack, Gunduz-Bruce, Sevy, & Robinson, 2009), increased risk for relapse 
(Alvarez-Jimenez et al., 2012; Hui et al., 2013), being male (Køster, Lajer, Lindhardt, & 
Rosenbaum, 2008; Thorup et al., 2014), an earlier age of onset (Coldham, Addington, & 
Addington, 2002), schizophrenia-spectrum diagnosis (Hui et al., 2013), poorer premorbid 
adjustment (Coldham, Addington, & Addington, 2002), poor social support (Rabinovitch, 
Bechard-Evans, Schmitz, Joober, & Malla, 2009), and unemployment or lower education 
level (i.e., poor occupational activity) (Leclerc, Noto, Bressan, & Brietzke, 2015). In 
addition, medication non-adherence has been reported to be essential for one’s sense of 
self-perceived recovery (Windell, Norman & Malla, 2012). 
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Social Support (Perceived)  
Social support has been reported to be associated with a decreased risk of relapse and 
increased engagement in occupational activity (Norman et al., 2005). In addition, social 
support has also been cited as an important factor to facilitate recovery from a first 
episode of psychosis (Windell & Norman, 2012). Poor social support has been reported 
to be associated with a long duration of untreated psychosis (Compton & Broussard, 
2011) and medication non-adherence (Rabinovitch, Bechard-Evans, Schmitz, Joober, & 
Malla, 2009). 
2.6! Detailed Thesis Objectives & Hypotheses  
All four objectives of this thesis are visually summarized in the conceptual framework 
(Figure 2.3) presented in the previous section. In this section, each of the four objectives 
and hypotheses will be described. In addition, the corresponding section of the conceptual 
framework depicting each objective will be highlighted using a simplified version of the 
conceptual framework. The simplified version includes the exposure, potential mediator, 
and outcome variables (Figure 2.4). 
 
Figure 2.4: Simplified Conceptual Framework. Note: DUP = Duration of Untreated 
Psychosis; SELF-PERCEIVED RECOVERY = Self-Perceived Recovery Score.  
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2.6.1! Objective 1 
Findings from empirical studies that have investigated the relationship between objective 
and subjective recovery from psychotic disorders (e.g. schizophrenia) or other serious 
mental illness have been equivocal, with evidence for and against the presence of an 
association (Jørgensen et al., 2015; Kukla, Lysaker, & Roe, 2014; Lloyd, King, & Moore, 
2010; Morland, 2007; Norman, Windell, & Manchanda, 2013; Resnick, Rosenheck, & 
Lehman, 2004; Roe, Mashiach-Eizenberg & Lysaker, 2011). Given these inconsistent 
findings, we sought to examine the association at 10-year follow-up between 
occupational activity (less than 52 weeks of the past year vs. 52 weeks of past year), an 
objective measure of recovery, and self-perceived recovery score, a subjective measure of 
recovery, among people 16 to 50 years of age who experienced a first episode of 
psychosis (Figure 2.5). 
 
Figure 2.5: Objective 1 depicted within the Simplified Conceptual Framework. Note: 
DUP = Duration of Untreated Psychosis; SELF-PERCEIVED RECOVERY = Self-
Perceived Recovery Score. 
Hypothesis 1 
We hypothesized that there would be a statistically significant positive association 
between occupational activity (i.e., objective recovery) and self-perceived recovery score 
(subjective recovery) at 10-year follow-up, such that people who engaged in occupational 
activity for 52 weeks of the past year would have higher self-perceived recovery scores.  
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2.6.2! Objective 2 
The study conducted by Austin and colleagues (2013) is the only study to date that has 
investigated whether the duration of untreated psychosis is associated with objective 
recovery among people with first-episode psychosis over a long follow-up period (>10-
years). To add to this essentially non-existent body of literature, we sought to investigate 
whether duration of untreated psychosis is associated with occupational activity (i.e., 
objective recovery) among people 16 to 50 years of age, 10-years after being treated for a 
first episode of psychosis, adjusting for gender, age of onset, and other confounding 
variables (Figure 2.6).  
 
Figure 2.6: Objective 2 depicted within the Simplified Conceptual Framework. Note: 
DUP = Duration of Untreated Psychosis; SELF-PERCEIVED RECOVERY = Self-
Perceived Recovery Score. 
Hypothesis 2 
We hypothesized that a longer duration of untreated psychosis would decrease the odds 
of engagement in occupational activity, adjusting for gender, age of onset, and other 
confounding variables. 
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2.6.3! Objective 3 
To our knowledge, no study to date has examined the association between the duration of 
untreated psychosis and subjective recovery among people with first-episode psychosis. 
To address this current gap in the literature, we investigated whether the duration of 
untreated psychosis is associated with self-perceived recovery score (i.e., subjective 
recovery) among people 16 to 50 years of age, 10-years after being treated for a first 
episode of psychosis, adjusting for gender, age of onset, and other confounding variables 
(Figure 2.7). 
 
Figure 2.7: Objective 3 depicted within the Simplified Conceptual Framework. Note: 
DUP = Duration of Untreated Psychosis; SELF-PERCEIVED RECOVERY = Self-
Perceived Recovery Score. 
Hypothesis 3 
We hypothesized that there will be a statistically significant negative association between 
the duration of untreated psychosis and self-perceived recovery score (i.e., subjective 
recovery), such that longer duration of untreated psychosis would be associated with 
lower self-perceived recovery scores, after adjusting for gender, age of onset, and other 
confounding variables.  
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2.6.4! Objective 4 
Vulnerability to relapse has been found to be associated with a long duration of untreated 
psychosis (Saravanan et al., 2010; Stefanescu, Macrea, Popescu, Ilies, & Miclutia, 2013), 
and it has also been perceived, by some, to be a barrier to one’s recovery from a first-
episode of psychosis (Maddigan, 2011; Windell, Norman, & Malla, 2012). We thus 
sought to investigate whether relapse mediates the relationship between the duration of 
untreated psychosis and self-perceived recovery score among people 16 to 50 years of 
age who experienced a first episode of psychosis, adjusting for gender, age of onset, and 
other confounding variables (Figure 2.8).  
 
Figure 2.8: Objective 4 depicted within the Simplified Conceptual Framework. Note: 
DUP = Duration of Untreated Psychosis; SELF-PERCEIVED RECOVERY = Self-
Perceived Recovery Score. 
Hypothesis 4  
We hypothesized that relapse will mediate the relationship between the duration of 
untreated psychosis and self-perceived recovery score (i.e., subjective recovery), such 
that a longer duration of untreated psychosis would be associated with greater relapse, 
which in turn would result in lower self-perceived recovery scores, after adjusting for 
gender, age of onset, and other confounding variables. 
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Chapter 3!!
3! Methods  
In this chapter, the data source is described in Section 3.1, followed by the study 
procedure for the follow-up assessments conducted at 10-years (i.e., 10-year follow-up 
study) in Section 3.2. In Section 3.3, the process to obtain access to the data of the source 
study will be discussed. Thereafter in Section 3.4, a description of the observations and 
variables used in the statistical analyses will be provided. Next in Section 3.5, missing 
data and the method to handle missing data will be described. Lastly, the statistical 
analysis plan will be described in Section 3.6.  
3.1! Data Source  
As mentioned in Chapter 1, this thesis used data from a prospective cohort study that 
assessed outcomes of clients 10-years following initial treatment for a first episode of 
psychosis, received from an early intervention program (PEPP; London, Canada). This 
study titled, “Assessment of 10 Year Outcomes for Clients of the Prevention and Early 
Intervention Program for Psychoses (PEPP)” received ethics approval from Western 
University’s Ethics Board for Health Sciences Research. No further ethics approval for 
this thesis was required since our objectives fell within the scope of the objectives of the 
prospective cohort study.  
PEPP is a comprehensive early psychosis intervention program that has been in operation 
since 1997 (Malla, Norman, McLean, Scholten, & Townsend, 2003; Norman & 
Manchanda, 2016), located in Zone A, on the 2nd floor of Victoria Hospital, London 
Health Sciences Centre (LHSC). This program is designed to treat non-affective first-
episode psychotic disorders, and has an open referral policy, which allows family 
members, individuals, and concerned persons (e.g., teacher) to make a referral. A 
physician referral is not required (Norman & Manchanda, 2016; www.PEPP.ca).  
Admission to PEPP is restricted to people who: 1) Are between the ages of 16 and 50 
years; 2) Are experiencing symptoms of a first-episode non-affective psychotic disorder; 
3) Have never been treated for psychosis or have taken antipsychotic medication for no 
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more than one month; 4) Do not suffer from organic brain damage, pervasive 
developmental disorder, epilepsy, or other brain disorders or injuries; 5) Have no current 
outstanding legal matters, such that contact with forensic psychiatric services is needed; 
and 6) Who live within the predominantly urban catchment area of Middlesex County 
and the city of London (www.PEPP.ca). People who meet these admission criteria are 
rapidly admitted to PEPP since this program does not have a waiting list (Norman & 
Manchanda, 2016). 
Following admission to PEPP, an individualized treatment plan is created in collaboration 
with the client, family (if applicable), and with other professionals involved in the client’s 
care including, but not limited to, a case manager, psychiatrist, or psychologist (Norman 
& Manchanda, 2016; www.PEPP.ca). The treatment plan includes medical management, 
psychosocial management, and case management (Malla, Norman, McLean, Scholten, & 
Townsend, 2003; Norman & Manchanda, 2016). Medical management refers to treatment 
by low-dose antipsychotic medication (primarily second-generation), prescribed by a 
psychiatrist to the client on a regular basis (Manchanda, Norman, Malla, Harricharan, & 
Northcott, 2008). Psychosocial management refers to treatment with psychosocial 
interventions such as individual supportive psychotherapy (i.e., cognitive behavioural 
therapy) (Malla, Norman, McLean, Scholten, & Townsend, 2003; Norman & 
Manchanda, 2016). Lastly, case management refers to treatment in the form of support 
and advocacy by one’s case manager. The case manager coordinates care, develops goals, 
and ensures the needs of the client are being met, among many other functions (Malla, 
Norman, McLean, Scholten, & Townsend, 2003; www.PEPP.ca). 
The treatment plan is structured around a modified case management model in which 
intensity of treatment is determined by the stage of a client’s illness, the client’s needs, 
and the needs of the client’s family (Malla, Norman, McLean, Scholten, & Townsend, 
2003). Each client will receive intense treatment for a minimum of two-years and up to a 
period of five-years (Malla, Norman, McLean, Scholten, & Townsend, 2003; Norman & 
Manchanda, 2016). Intense treatment involves the client receiving all forms of treatment 
offered by PEPP. At the end of the two-year treatment period, the clinical status of the 
client is assessed to determine whether to provide him or her with extended treatment in 
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the form of both medication management and case management (one- to three-years) or 
to provide less intense treatment in the form of medication management only (Malla, 
Norman, McLean, Scholten, & Townsend, 2003; Norman, Manchanda, Malla, Windell, 
Harricharan, & Northcott, 2011). Throughout the two to five-year period, the clinical 
status of the client is assessed every three to six months to determine whether to provide 
the client with greater or lesser treatment (Norman, Manchanda, Malla, Windell, 
Harricharan, & Northcott, 2011). 
3.2! Study Procedure  
The prospective cohort study (i.e., source study) collected data from clients at baseline, 5-
year follow-up, and again at 10-year follow-up. We will focus our discussion of study 
procedures pertaining mainly to the follow-up assessment conducted 10-years following 
initial treatment for first-episode psychosis at PEPP. 
3.2.1! Participant Recruitment 
Between March 1997 and February 2002, a total of 132 people were admitted to PEPP. 
Each person provided informed consent to which he or she agreed to be followed-up for 
outcome assessments even if he or she was no longer receiving treatment at PEPP, as 
described in the letter of information (Malla et al., 2002; Norman, Manchanda, Malla, 
Windell, Harricharan & Northcott, 2011).  
The eligibility criteria to take part in the source study were the same as the admission 
criteria for PEPP (Section 2.1). Additional eligibility criteria for participation in the study 
included: 1) Ability to speak or understand English; 2) Competent and willing to provide 
written informed consent; 3) Diagnosed with a non-affective psychotic disorder that 
meets Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) 
criteria; and 4) Current Outpatient Status. 
3.2.2! Follow-up Assessments 
Between February 2014 and June 2015, the research coordinator at PEPP re-contacted 
some of the 132 clients admitted to PEPP between March 1997 and February 2002, with 
a request to participate in the 10-year follow-up assessment. Clients were re-contacted if 
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at least 10-years had elapsed since receiving initial treatment for a first episode of 
psychosis at PEPP. If the client agreed to participate, an assessment interview was 
scheduled at a time convenient for the client.  
3.2.3! Assessment Interviews  
Participation in the 10-year follow-up assessment involved the completion of an outcome 
assessment that included a battery of clinical and non-clinical outcome measures, some of 
which were also administered at 5-year follow-up. Completion of the outcome 
assessment was split between two assessment interviews that were scheduled a week or 
two apart. A random number system was used to determine the order in which outcome 
measures were to be administered to the participant in either the first and/or second 
assessment interview. The random number system is described in Figure 3.1.  
 
Figure 3.1: Random Number System. Note: Determined the order in which non-clinical 
and clinical outcome measures were to be administered during the first and/or second 
assessment interview; LTO = Long Term Outcome.  
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When the participant arrived for his or her first assessment interview, written informed 
consent was obtained. Demographic information was then obtained from the participant 
by use of a demographics questionnaire, and outcome measures were administered in a 
semi-structured interview format. Non-clinical outcome measures were administered to 
the participant by the research coordinator, who was trained and supervised by a licensed 
clinical psychologist. A licensed clinical psychologist or psychiatrist with PEPP 
administered all clinical outcome measures to the participant, ensuring a standardized 
presentation of study measures. Inter-rater reliability between these two clinicians with 
PEPP was good (Interclass correlation coefficient = 0.80). Outcome measures were 
administered verbally to participants with literacy or comprehension problems. 
As the participant was completing the outcome measures, the interviewer took note of the 
participant’s tolerance level, energy level, and level of cognitive functioning. Based on 
these factors, the participant may have been encouraged to take a break or to complete the 
rest of the interview another day. If a participant did not complete the 10-year assessment 
during the first interview, a second assessment interview was scheduled a week or two 
later. 
Most participants completed the 10-year follow-up assessment over two interviews. Each 
assessment interview took between 1 to 1.5 hours to complete. All assessment interviews 
were conducted in research offices at PEPP. For each of the assessment interviews, 
participants were reimbursed for their time in the amount of $30.00, as well as their travel 
expenses in the form of a parking pass or bus tickets. Participants were also provided 
with snacks and water at each of the assessment interviews.  
3.3! Data Set 
3.3.1! Data Access Process 
Obtaining access to data from the prospective cohort study consisted of five steps. The 
first step involved having a meeting with the primary investigator of the source study. 
The purpose of this meeting was two-fold. First, to determine which studies were 
currently being conducted using the same data set, and second, to discuss possible 
research questions based on research currently being conducted in the field. The second 
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step involved formulating objectives and a statistical plan based on available data. The 
third step involved submitting a request for access to a subset of variables, which was 
submitted to the primary investigator. The fourth step involved the primary investigator 
extracting the requested variables from the main PEPP database containing demographic 
and longitudinal outcome data, and creating a data set. The final step of this process 
involved the primary investigator transferring the de-identified data set. 
3.3.2! Data Cleaning 
Upon receiving the data set, we used Stat/Transfer to convert the data from SPSS format 
to Stata format (sav to .dta). We then used Stata, version 14 (StataCorp, 2015) to ‘clean’ 
the data. This included dropping variables that were not required for pre-specified 
analyses, and checking for temporal consistency of data, distributions of all variables, and 
for potential outliers. Additional data cleaning included relabeling variables, recoding of 
variables, and transforming variables with a skewed distribution. 
3.4! Variables & Measures 
3.4.1! Exposure Variable 
Duration of Untreated Psychosis  
Duration of untreated psychosis was defined as the length of time in weeks between the 
date of onset of positive psychotic symptoms (e.g., hallucination) to the date of initiation 
of adequate treatment for 1-month. Adequate treatment referred to treatment with 
antipsychotic medication for 1-month (or until symptoms have resolved) or psychosocial 
treatment (i.e., assertive case management) for 1-month. These dates were extracted from 
select items from the CORS as part of the baseline assessment (Norman & Malla, 2002). 
The CORS is a semi-structured questionnaire administered at baseline by trained research 
assistants. This questionnaire is divided into five main sections: 1) Identifying 
Information; 2) Demographic Information; 3) Family Structure and Health; 4) Pathways 
to Care; and 5) Topography of Psychotic Episode (TOPE). In completing the CORS, 
information was obtained from the client, family, and referring source. 
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The CORS has been used in previous first-episode psychosis studies (e.g., Flanagan & 
Compton, 2012; Franz et al., 2010; Monte, Golding, & Compton, 2008), and has 
demonstrated excellent interrater reliability with ICC’s ranging from 0.86 to 0.90 for the 
duration of untreated psychosis and for the duration of untreated illness (Iyer et al., 
2008).    
We assessed the distribution of the duration of untreated psychosis, which was observed 
to be positively skewed. For comparability of results, we normalized the duration of 
untreated psychosis distribution by taking the logarithm to base10 (log10), a routine 
approach used by other researchers in the field (e.g., Austin et al., 2013; Gumley et al., 
2014; Norman et al., 2012). For all analyses conducted in this thesis, we used the 
duration of untreated psychosis (i.e., transformed version) as a continuous variable.  
3.4.2! Outcome Variables 
Self-Perceived Recovery 
Self-perceived recovery was assessed at 10-year follow-up using the MARS (Bellack & 
Drapalski, 2012), a self-report measure of one’s perceived status of recovery from serious 
mental illness. The MARS consists of 25-items, each scored on a 5-point Likert scale 
ranging from 1-Strongly Disagree to 5-Strongly Agree. The MARS covers six 
components of recovery based on those identified by SAMHSA, including self-direction 
(e.g., “I usually know what is best for me.”) or empowerment (e.g., “I have abilities that 
can help me reach my goals.”), holistic (e.g., “I feel accepted as who I am.”), non-linear 
(e.g., “When I have a relapse, I am sure that I can get back on track.”), strengths-based 
(e.g., “My strengths are more important than my weaknesses.”), responsibility (e.g., “I 
am responsible for making changes in my life.”), and hope (e.g., “I am hopeful about the 
future.”). All six components are considered to be essential to recovery and each domain 
exclusively focuses on measureable aspects of the person (Drapalski et al., 2012). 
The MARS has demonstrated strong internal consistency for the entire measure (α = 
0.95), as well as strong test-retest reliability (α = 0.898) when used with a sample of 166 
people with severe mental illness including schizophrenia, schizoaffective disorder, 
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bipolar I disorder, or major depression with psychotic features (Drapalski et al., 2012). 
This empirical measure can be used for both research and clinical purposes (Bellack & 
Drapalski, 2012).  
For the purpose of this thesis, we used the total MARS score as an overall assessment of 
self-perceived recovery. Total scores on this uni-dimensional measure range from 25 to 
125. Higher scores are indicative of greater self-perceived recovery from severe mental 
illness. Self-perceived recovery score was used as a subjective measure of recovery. We 
used self-perceived recovery score at 10-year follow-up as a continuous variable in all 
analyses.  
Occupational Activity 
Occupational activity included engagement in work and/or school on a full-time or part-
time basis in the past year. This was assessed at 10-year follow-up using items from the 
Life Chart Schedule (LCS) (WHO, 1992), which was designed to assess the long-term 
outcomes and course of schizophrenia in four domains: Symptoms, treatment, residence, 
and work (Sartorius, Gulbinat, Harrison, Laska, & Siegel, 1996). Specifically, we used 
items 2, 3, 10, and 11 of the 16-item modified “Work & Disability” subscale. Items 2 
(“Weeks in full-time jobs.”) and 3 (“Weeks in part-time jobs.”) were used to assess the 
number of weeks during the past year the participant was employed full-time or part-
time. Items 10 (“Weeks as full-time student.”) and 11 (“Weeks as part-time student.”) 
were used to assess the number of weeks during the past year the participant attended 
school on a full-time or part-time basis.  
We generated the occupational activity variable by summing together responses for Items 
2 (“Weeks in full-time jobs.”), 3 (“Weeks in part-time jobs.”), 10 (“Weeks as full-time 
student.”), and 11 (“Weeks as part-time student.”) of the 16-item modified “Work and 
Disability” subscale of the LCS. We followed the approach that Norman and colleagues 
(2007; 2012) have used to compute and assess occupational activity among people with 
first-episode psychosis. However, we additionally included engagement in work and/or 
school on a part-time basis. Psychometric information for the use of this approach was 
not available.  
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We assessed the distribution of weeks of occupational activity, which was observed to be 
bimodal. We therefore decided to dichotomize weeks of occupational activity by using 
the median as the cut-point. Thus, participants were engaged in occupational activity for 
either 52 weeks of the past year or for less than 52 weeks of the past year. Occupational 
activity was used as an objective measure of recovery. We used occupational activity at 
10-year follow-up as a dichotomous variable in all analyses. 
3.4.3! Mediator Variable 
Relapse  
We used number of hospitalizations for a mental health reason, as derived from medical 
charts, as a proxy indicator for relapse. Number of hospitalizations were extracted from 
baseline to 5-year follow-up (time 1) and from 5-year follow-up to 10-year follow-up 
(time 2). The number of hospitalizations at time 2 were used in the mediation analysis.  
A more accurate measure of relapse is the recurrence of the positive symptoms of 
psychosis, however, these data were not collected between the 5- and 10-year follow-up 
periods. Nonetheless, hospitalization data are a sensitive (87%), yet, non-specific (47%) 
indicator of relapse among people with first-episode psychosis (Addington, Patten, 
McKenzie, & Addington, 2013). 
3.4.4! Potential Confounding Variables 
For all analyses, we adjusted for 11 of the 13 variables we identified as potential 
confounders in our conceptual framework (Chapter 2). A description of the inter-
relationships among the exposure variable, the two outcome variables, the mediator 
variable, and the potential confounding variables is provided in Chapter 2. A rationale for 
why we did not adjust for two of the potential confounding variables in all analyses is 
provided in this section.  
Gender 
Gender was assessed at baseline using the demographics questionnaire, with response 
options of either Male or Female.  
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Age of Onset 
Age of onset refers to one’s chronological age at the time of the first onset of psychotic 
symptoms (e.g., hallucinations) (Norman et al., 2007). To calculate age of onset, date of 
birth and date of first change were obtained from the TOPE section of the CORS 
(Norman & Malla, 2002). At baseline, information for the CORS was obtained from 
patient reports and combined with any information provided by the family and referral 
source. We used age of onset as a continuous variable in all analyses.  
Mode of Onset 
Mode of onset refers to how quickly psychotic symptoms develop over the course of a 
first episode of psychosis (Compton, 2010). Mode of onset was calculated by subtracting 
date of onset of psychosis (day/month/year) from date of first change (day/month/year), 
which were obtained from the CORS (Norman & Malla, 2002). At baseline, information 
was obtained from patient reports and combined with any information provided by the 
family and referral source. 
Mode of onset was used as a dichotomous variable in all analyses, with participants 
labelled with insidious or acute mode of onset. An insidious mode of onset was defined 
as equal or greater to 1-month, and an acute mode of onset defined as less than 1-month.  
Diagnosis of a Psychotic Disorder 
A primary diagnosis of a non-affective psychotic disorder was made at baseline using the 
Structured Clinical Interview for DSM-IV Axis I Disorders-Clinician Version (SCID-
CV) (First, Spitzer, Gibbon, & Williams, 1995). The SCID-CV is a semi-structured 
interview that was administered by trained research assistants and cross-checked with the 
treating clinician. In completing the SCID-CV, information was obtained from various 
sources including client report, information provided by family, and any available 
medical records. 
The SCID-CV is comprised of three main sections: 1) Overview; 2) Modules A to F; and 
3) Diagnostic Summary. The modules section of the SCID-CV is used for the purposes of 
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making a diagnosis. This section is comprised of six modules corresponding to six 
diagnostic categories: A) Mood Episodes (69-items); B) Psychotic and Associated 
Symptoms (15-items); C) Differential Diagnosis of Psychotic Disorders (39-items); D) 
Mood Disorders (19-items); E) Alcohol and Other Substance Use Disorders (32-items); 
and F) Anxiety and Other Disorders (91-items). Modules C and D were used to make a 
diagnosis of a psychotic disorder.   
Items within each module correspond to specific criteria or symptoms of a specific 
disorder. Items are rated according to one of the two response ratings: 1) Inadequate 
information (?), Absent/Subthreshold (-), Present (+); or 2) Yes/No. Some items are 
skipped depending on how that item was rated. For each disorder, a certain number of 
criteria/symptoms or certain criteria/symptoms must be present (rated as either + or Yes) 
in order to be diagnosed with a particular disorder.  
We dichotomized diagnosis into schizophrenia-spectrum or other psychotic disorder. 
We categorized the following diagnoses as schizophrenia-spectrum: Schizophrenia-
Disorganized; Schizophrenia-Paranoid; Schizophreniform; Schizoaffective; and 
Schizophrenia-Undifferentiated. We then categorized the remaining diagnoses as other 
psychotic disorder: Substance-Induced Psychosis; Bipolar I with Psychotic Features; 
Major Depression with Psychotic Features; Brief Psychotic Disorder; and Psychosis Not 
Otherwise Specified.  
Premorbid Adjustment 
Premorbid adjustment refers to the person’s psychosocial functioning before the onset of 
psychotic illness or symptoms (Cannon-Spoor, Potkin, & Wyatt, 1982), and was assessed 
at baseline using the Premorbid Adjustment Scale (PAS; Cannon-Spoor, Potkin, & 
Wyatt, 1982). The PAS is a rating scale that assesses premorbid adjustment from a 
developmental perspective. This scale consists of a general section and four sections 
pertaining to distinct developmental age periods including childhood (up to 11 years), 
early adolescence (12 to 15 years), late adolescence (16 to 18 years), and adulthood (19 
years and above). Within each of the four developmental age periods, all or some of the 
following five domains of psychosocial functioning are assessed: 1) Sociability and 
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withdrawal; 2) Peer relationships; 3) Scholastic performance; 4) Adaptation to school; 
and 5) Ability to form social-sexual relationships. Ability to form social-sexual 
relationships is not included nor assessed in the childhood period, while scholastic 
performance and adaption to school are not included nor assessed in the adulthood 
period. The general section contains items assessing energy level, interest in life, 
independence, education, social-personal adjustment, highest level of global functioning 
achieved, work (employed for pay, change in work, and frequency of job change), or 
school (attendance, functioning, and performance). This section was not completed by 
participants in the baseline assessment. 
To minimize confounding of onset of illness and premorbid adjustment, ratings from the 
late adolescence and adulthood periods were excluded from the analysis because onset of 
psychotic or early symptoms generally occurs in late adolescence or early adulthood 
(Norman, Malla, & Manchanda, 2007). Thus, ratings of items from the childhood and 
early adolescence periods were used to assess premorbid adjustment, specifically items 
pertaining to the sociability and scholastic performance domains. Each item was rated on 
a Likert-type scale ranging from 0 to 6. For each psychosocial domain assessed in these 
age periods, ratings were summed and divided by the total possible rating, resulting in an 
index varying between 0 and 6, with higher scores indicating worse adjustment. All 
ratings were made with reference to the premorbid period, which ends 6-months before 
the onset of positive psychotic symptoms (Cannon-Spoor, Potkin, & Wyatt, 1982). 
Ratings were based on information obtained from patient reports and combined with any 
information provided by the family and referral source.  
With respect to psychometric properties, Brill and colleagues (2008) results support the 
predictive and concurrent validity of the PAS when used with 91 males with 
schizophrenia or schizoaffective disorder, based on the Pearson correlations between the 
PAS (school achievements and school adjustment items) and the Draft Board’s 
(functioning in structured environments scale) concurrent ratings (r = 0.71 and r = 0.72) 
and ratings obtained again at the age of 17 years (re-administered; r = 0.43 and r = 0.47). 
The PAS also demonstrated good scale reliability: Childhood (α = 0.72; four items); 
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Early adolescence (α = 0.79; five items);  and Late adolescence (α = 0.79; five items) 
(Brill, Reichenberg, Weiser, & Rabinowitz, 2008).   
We used the overall premorbid adjustment scale rating for childhood and adolescence 
(i.e., premorbid adjustment score) as a continuous variable in our descriptive analysis. 
We were unable to use this variable in our simple and multivariable regression analyses 
because of the lack of variability in the distribution of scores. 
Positive Symptoms 
The presence and severity of the positive symptoms of psychosis were assessed at 
baseline, 5-year follow-up, and 10-year follow-up using the Scale for the Assessment of 
Positive Symptoms (SAPS; Andreasen, 1984). The SAPS consists of 34-items, each rated 
on a 6-point Likert-type scale ranging from 0-Absent to 5-Severe. The SAPS yields 
cumulative ratings and subscale ratings (i.e., global ratings) pertaining to four positive 
symptoms: 1) Hallucinations (7 items; e.g., Visual Hallucinations, “The patient sees 
shapes or people that are not actually present.”); 2) Delusions (13 items; e.g., Thought 
Insertion, “The patient believes that thoughts that are not his or her own have been 
inserted into his or her head.”); 3) Bizarre Behaviour (5 items; e.g., Repetitive or 
Stereotyped Behaviour, “The patient develops a set of repetitive actions or rituals that he 
or she must perform over and over.”); and 4) Positive Formal Thought Disorder (9 
items; e.g., “Tangentiality, “Replying to a question in an oblique or irrelevant manner.”).  
All ratings were completed with reference to the past month. Cumulative ratings range 
from 0 to 170, with higher ratings reflective of a greater severity of positive symptoms. 
Global ratings for each positive symptom range from 0 to 20, with higher ratings 
reflective of a greater severity of a particular positive symptom.  
The SAPS has been used in previous first-episode psychosis studies (e.g., Austin et al., 
2015; Malla et al., 2008; Norman, Malla, & Manchanda, 2007), but specific psychometric 
information was not provided. 
To obtain a single continuous measure of severity of positive symptoms, we computed a 
composite score using the global ratings of each of the four positive symptoms (Noman et 
62 
 
al., 2012). We used the positive symptoms scores at baseline and 10-year follow-up as 
continuous variables in all analyses.  
Negative Symptoms 
The presence and severity of the negative symptoms of psychosis were assessed at 
baseline, 5-year follow-up, and 10-year follow-up using the Scale for the Assessment of 
Negative Symptoms (SANS; Andreasen, 1983). The SANS consists of 25-items, each 
rated on a 6-point Likert-type scale ranging from 0-Absent to 5-Severe. The SANS yields 
cumulative ratings and subscale ratings (i.e., global ratings) pertaining to five negative 
symptoms: 1) Affective Flattening or Blunting (8 items; e.g., Affective Nonresponsivity, 
“The patient fails to laugh or smile when prompted.”); 2) Alogia (5 items; e.g., Poverty of 
Speech, “The patient’s replies to questions are restricted in amount, tend to be brief, 
concrete, unelaborated.”); 3) Avolition-Apathy (4 items; e.g., Physical Anergia, “The 
patient tends to be physically inert. He or she may sit for hours and not initiate 
spontaneous activity.”); 4) Anhedonia-Asociality (5 items; e.g., Ability to Feel Intimacy 
and Closeness, “The patient may display an inability to form close or intimate 
relationships, especially with opposite sex and family.”); and 5) Attention (3 items; 
Social Inattentiveness, “The patient appears uninvolved or unengaged. He or she may 
seem spacey.”). 
All ratings were completed with reference to the past month. Cumulative ratings range 
from 0 to 125, with higher ratings reflective of a greater severity of negative symptoms. 
Global ratings for each negative symptom range from 0 to 25, with higher ratings 
reflective of a greater severity of a particular negative symptom. 
The SANS was initially developed for those with a diagnosis of schizophrenia. However, 
a recent study reported that the SANS structure was similar among a sample of people 
with first-episode schizophrenia spectrum (n = 191) or non-schizophrenia spectrum (n = 
246) diagnoses, thus supporting the use of the SANS among people with first-episode 
psychosis (Lyne et al., 2013). The SANS has been used in previous first-episode 
psychosis studies (e.g., Austin et al., 2015; Lyne et al., 2013; Malla et al., 2008; Norman, 
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Malla, & Manchanda, 2007), and has been reported to have good psychometric properties 
(Lyne et al., 2013); however, specific psychometric information was not provided.  
To obtain a single continuous measure of severity of negative symptoms, we computed a 
composite score using the global ratings of each of the five negative symptoms (Norman 
et al., 2012). We used the negative symptoms scores at baseline and 10-year follow-up as 
continuous variables in all analyses.  
Highest Level of Education 
Highest level of education attained was assessed at 10-year follow-up using the 
demographics questionnaire. The response options for highest level of education 
included: “No formal schooling completed,” “Elementary School (8th grade),” “Some 
High School (no diploma),” “High School graduate or the equivalent (GED),” Some 
college or university (no degree/diploma),” “Trade/technical/vocational training,” 
“College,” “University,” and “Graduate School.” Information collected on participants’ 
highest level of education was used as a proxy indicator of socioeconomic status. Based 
on the lack of variability in response options, we recoded this variable to allow 
participants to be grouped into one of two levels of education: 1) Less than or completed 
high school; 2) Some post-secondary or higher.  
Social Support (Perceived) 
Social support was assessed at 10-year follow-up using the Interpersonal Support 
Evaluation List (ISEL; Cohen, Mermelstein, Kamarck, & Hoberman, 1985), a 40-item, 
dichotomously scored (Probably True /Probably False) self-report measure of perceived 
social support. The ISEL yields total scores and subscale scores assessing four domains 
of social support including appraisal (10 items; e.g., “There is at least one person I know 
whose advice I really trust.”), tangible (10 items; e.g., “If I needed a quick emergency 
loan of $100, there is someone I could get it from.”), self-esteem (10 items; e.g., Most of 
my friends are more interesting than I am.”), and belonging (10 items; e.g., “When I feel 
lonely, there are several people I could call and talk to.”). The appraisal subscale 
measures a person’s perception of having someone to talk to about his or her problems. 
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The tangible subscale measures a person’s perception of having someone to provide 
material aid. The self-esteem subscale measures a person’s perception of having someone 
that will provide positive comparison when comparing him or herself to others. The 
belonging subscale measures a person’s perception of having people with whom he or 
she can do things with.  
The ISEL has demonstrated strong internal consistency (α = 0.93) and high 4-month test-
retest reliability (r = 0.83) among a sample of 59 people with a diagnosis of bipolar I 
disorder (Johnson, Winett, Meyer, Greenhouse, & Miller, 1999). Total scores on this 
measure range from 0 to 40. Higher scores are indicative of greater perceived social 
support. 
To obtain a single continuous measure of perceived social support, we computed a 
composite score using the subscale ratings of each of the four domains of social support, 
and the perceived social support score was used as a continuous variable in all analyses.  
Drug Use 
Drug use was assessed at baseline, 5-year follow-up, and 10-year follow-up using the 20-
item Drug Abuse Screening Test (DAST-20; Skinner, 1982), a self-report measure of 
one’s involvement and abuse of drugs in the last 3-months (e.g., “In the last 3 months, 
have you used drugs other than those required for medical reasons?”). For the purposes 
of the DAST-20, drug use is operationalized as any non-medical use of drugs (i.e., street 
drugs). Non-medical use of drugs does not include alcohol.  
All 20-items on this uni-dimensional measure are dichotomously scored (Yes/No). A 
score of “1” is given for each Yes response, except for items 4 (“Did you get through the 
week without using drugs (other than those required for medical reasons)?”) and 5 
(“Were you always able to stop using drugs when you want to?”), for which a No 
response is given a score of “1.” If the response to item 1 (“Have you used drugs other 
than those required for medical reasons?”) and item 2 (“Have you abused prescription 
drugs?”) are both “No,” the remaining 18-items are not to be completed. Total scores on 
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this measure range from 0 to 20, with higher scores indicating a greater severity of drug 
use.  
The use of a cut-off score of 3 or above (sensitivity, 85%; specificity; 73%) on the 
DAST-20 has been recommended for optimal detection of problem drug use in a sample 
of people with first-episode psychosis sampled from an early intervention service, as 
compared to the conventional score of 6 or above (sensitivity, 55%; specificity; 86%) 
(Cassidy, Schmitz, & Malla, 2008).  
The DAST-20 has demonstrated strong internal consistency when used with a sample of 
128 people with first-episode psychosis (α = 0.998) (Cassidy, Schmitz, & Malla, 2008), 
and has demonstrated good test/retest reliability (ICC = 0.78) when used with a sample of 
97 outpatients with an Axis I disorder, other than substance abuse or dependence (e.g., 
schizophrenia) (Cocco & Carey, 1998).   
We did not use not use either of the cut-off score recommendations (i.e., 3 or 6) because a 
majority of the participants had a score of zero (i.e., no drug use) at 10-year follow-up. 
We therefore dichotomized drug use at 10-year follow-up into Yes, indicative of any drug 
use (DAST-20 score is greater than zero) or No, indicative of no drug use (DAST-20 
score is zero).  
Medication Adherence  
Adherence to first- or second-generation antipsychotic medication was assessed at 5-year 
follow-up and at 10-year follow-up using a single-item question pertaining to the past 
month and year: “Based on all available information, approximately what percentage of 
time has the patient been taking medication as prescribed.” This question was 
formulated based on findings from a comparison study of multiple measures of adherence 
to antipsychotic medication in first-episode psychosis by Cassidy and colleagues (2010). 
Responses reflected the interviewer’s estimate of medication adherence based on 
information from four different subjective sources including the client, the case manager, 
the family, and the treating clinician. The estimate was rated on a four-point scale: 1 (0-
25%), 2 (26-50%), 3 (51-75%), and 4 (76-100%). In the event that the sources disagreed, 
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the case was discussed and a consensus was reached based upon all available 
information; however, the treating clinician's estimation carried the most weight. 
The reliability of using a consensus rating of medication adherence based on different 
sources has been examined in a study involving a sample of 81 clients with first-episode 
psychosis, treated at a specialized early intervention service in Montreal, Quebec 
(Cassidy, Rabinovitch, Schmitz, Joober, & Malla, 2010). The researchers reported that 
there was good agreement between measures of adherence obtained from three different 
sources including pill count, clinician report, and patient report (ICC = 0.84) (Cassidy, 
Rabinovitch, Schmitz, Joober, & Malla, 2010). 
Due to the lack of variability in ratings, we recoded medication adherence at 10-year 
from a categorical variable to a dichotomous variable. Participants were grouped into 
either less than or equal to 75% medication adherence (ratings 1 or 3) or greater than 75% 
medication adherence (rating 4). Medication adherence at 10-year follow-up was reported 
as a dichotomous variable in our descriptive analysis, but we were unable to use this 
variable in our multivariable analyses due to a lack of variability in its distribution.   
3.5! Missing Data 
3.5.1! Missing Data Approaches 
We examined the amount of missing data using the following approaches:                       
1) Determining the total number of observations (i.e., participants) with missing data (i.e., 
missing data for one or more variables); 2) Determining the total number of variables 
with an observation (i.e., participant) missing data; 3) Calculating the amount of missing 
data for the exposure, outcomes, potential mediator, and potential confounding variables; 
and 4) Examining the pattern and mechanism of missing data. Findings for the first three 
missing data approaches are presented in Table 3.1. 
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Table 3.1: Missing Data Approaches. 
Missing Data Approach n (Percent Missing) 
1. Total number of observations with missing data 28 (41.2%) 
2. Total number of variables with missing data (i.e., observation) 26 (60.5%) 
3. Total missing data for exposure, outcomes, potential mediator, and potential confounding variables 
Exposure 
Duration of Untreated Psychosis (weeks) 1 (1.5%) 
Outcomes  
Occupational Activity (Less than 52 weeks of past year vs. 52 weeks of past year) 1 (1.5%) 
Self-Perceived Recovery Score  2 (2.9%) 
Mediator (Assessment Point) 
Number of Hospital Admissions (Baseline to 5-year follow-up; time 1)** 12 (17.7%) 
Number of Hospital Admissions (5-year to 10-year follow-up; time 2)  1 (1.5%) 
Potential Confounding Variables (Assessment Point) 
Gender (Baseline) 0 (0.0%) 
Diagnosis of a Psychotic Disorder (Baseline) 0 (0.0%) 
Positive Symptoms (10-year follow-up) 0 (0.0%) 
Negative Symptoms (10-year follow-up) 0 (0.0%) 
Highest Level of Education (10-year follow-up) 0 (0.0%) 
Drug Use (10-year follow-up)  0 (0.0%) 
Mode of Onset (Baseline) 1 (1.5%) 
Perceived Social Support Score (10-year follow-up)  1 (1.5%) 
Age of Onset (Baseline) 2 (2.9%) 
Positive Symptoms (Baseline) 3 (4.4%) 
Negative Symptoms (Baseline)  3 (4.4%) 
Medication Adherence (10-year follow-up) + 4 (5.9%) 
Premorbid Adjustment Score (Baseline) + 9 (13.2%) 
Positive Symptoms (5-year follow-up) ** 12 (17.7%) 
Negative Symptoms (5-year follow-up)** 13 (19.1%) 
Medication Adherence (5-year follow-up) ** 14 (20.6%) 
Drug Use (5-year follow-up) ** 20 (29.4%) 
Drug Use (Baseline) ** 40 (58.8%) 
Note: **Variables missing a large percentage of data and were excluded for all analyses; +Variables 
not included in all analyses; n = Count; Observation = Participant; Total number of observations = 68; 
Total number of variables = 43.  
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For the final missing data approach, we examined the pattern and mechanism of missing 
data. We had to distinguish between two patterns of missing data: 1) Monotone; and 2) 
Arbitrary (Bouhlila & Sellaouti, 2013). A missing monotone pattern exists if one can 
observe a clear pattern among the missing values. If no clear pattern is observed, then the 
pattern of missing data is referred to as missing arbitrarily, also referred to as general or 
non-monotone (Munguía & Armando, 2014). 
In addition to determining the pattern of missing data, we further determined the 
mechanism of missing data for which three such mechanisms exist: 1) Missing 
completely at random (MCAR); 2) Missing at random (MAR); and 3) Missing not at 
random (MNAR) (Little & Rubin, 2002; Rubin, 1976). MCAR describes the case where 
the probability a data value missing for a particular variable is unrelated to other 
measured (or observed) variables in the data set and is unrelated to the variable with 
missing values itself. MAR refers to the case where the probability a data value is 
missing for a variable is related to other measured (or observed) variables in the data set, 
but unrelated to the variable with missing data itself. Lastly, MNAR, sometimes called 
not missing at random (NMAR), describes the case where the probability a data value is 
missing for a particular variable depends on the unobserved (i.e., missing) value for the 
variable itself (Nakai & Ke, 2011; Vittinghoff, Glidden, Schiboski, & McCulloch, 2011).  
We assumed the pattern of missing data to be missing arbitrarily and we assumed the 
mechanism of missing to be MAR for all data, except for all data collected at 5-year 
follow-up. For number of hospitalizations (time 1) and for data collected at 5-year 
follow-up including medication adherence, drug use, positive and negative symptoms, we 
assumed the pattern of missing data to be monotone and the mechanism of missing data 
to be MNAR because these data were missing for those who refused to participate in the 
5-year follow-up assessment. We therefore excluded all data collected at 5-year follow-
up from all analyses.   
3.5.2! Method to Handle Missing Data  
The pattern and mechanism of missing data, along with our intention to retain our entire 
sample (n = 68) guided our approach to use multiple imputation (MI) to handle missing 
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data in our data set (Vittinghoff, Glidden, Schiboski, & McCulloch, 2011). Compared to 
single imputation methods such as mean imputation where the missing value is imputed 
with the sample mean (Figure 3.2), in MI, a missing value is imputed multiple times (m 
times) by a set of plausible values sampled from an imputation model (Karahalios, 
Baglietto, Carline, English, & Simpson, 2012; Vittinghoff, Glidden, Schiboski, & 
McCulloch, 2011; White, Royston, & Wood, 2011).  
Prior to executing MI, we had to decide whether we wanted to construct our imputation 
model using the multivariate normal or the chained equations approach (Bouhlila & 
Sellaouti, 2013; Karahalios, Baglietto, Carline, English, & Simpson, 2012; Vittinghoff, 
Glidden, Schiboski, & McCulloch, 2011), and we had to decide on the number of 
imputations (m). We decided to use the chained equations approach, sometimes referred 
to as imputation using chain equations (ICE) or multiple imputation by chained equations 
(MICE) (Bouhlila & Sellaouti, 2013). We selected MICE because of its unique ability to 
handle different types of variables such as continuous, binary, and categorical, by 
modelling each variable using a model tailored to its distribution. For instance, linear 
regression for a continuous variable and logistic regression for a binary variable. 
(Bouhlila & Sellaouti, 2013; Vittinghoff, Glidden, Schiboski, & McCulloch, 2011). We 
also selected 50 imputations (m = 50) based on the following rule of thumb, “The number 
of imputations should be similar to the percentage of cases that are incomplete” (Bodner, 
2008; Von Hippel, 2009). We did not impute data for our outcomes of interest, and 
participants missing these data were excluded (n = 3).  
The execution of MI involves three steps (Figure 3.2); 1) Impute -The missing values are 
imputed m times to generate m complete data sets by sampling from a specified 
imputation model; 2) Analyze- The m completed data sets are analyzed to obtain m sets 
of parameter estimates and corresponding standard errors; and 3) Pool- The parameter 
estimates and corresponding standard errors and confidence intervals for each of the m 
complete data sets are averaged to yield one overall MI estimate (Biering, Hjollund, & 
Frydenburg, 2015; Nakai & Ke, 2011; White, Royston, & Wood, 2011). To obtain valid 
statistical inferences, the mechanism of missing data is assumed to be MAR (Bouhlila & 
Sellaouti, 2013; Little & Rubin, 2002). In order to obtain valid statistical inferences with 
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MI, we decided to exclude variables (i.e., all 5-year follow-up data) with missing data 
assumed to be MNAR from the imputation model and from the regression models. We 
also incorporated a seed number in the first step of MI in order to ensure replicability of 
results. 
 
Figure 3.2: Conceptual Depiction of the Single Imputation Process and the Multiple 
Imputation Process (m = 4). Note: Modified from Nakagawa & Freckleton (2008). 
Panel (A) Visually illustrates the process of single imputation. Panel (B) Visually 
illustrates the process of multiple imputation. 
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To ensure that our execution of MI worked, we conducted a few diagnostic checks to 
compare means and frequencies of observed and computed data, as well as looking at the 
variance information such as relative increase in variance, fraction of missing 
information, degrees of freedom, relative efficiency, and between and within variance 
estimates (UCLA, 2016). 
3.6! Statistical Analyses 
We conducted all statistical analyses using Stata, version 14 (StataCorp, 2015), and we 
conducted all hypothesis tests using a Type I error rate set at α = 0.05, two-tailed.  
3.6.1! Attrition Analysis 
We conducted an attrition analysis, comparing baseline sociodemographic and clinical 
characteristics between those who participated in the 10-year follow-up assessment and 
those who did not. For comparison of continuous baseline characteristics, we conducted a 
two independent samples t-test, and for comparison of categorical baseline 
characteristics, we conducted a chi-square test or Fisher’s exact test.  
3.6.2! Descriptive Statistics 
For all included participants, we computed descriptive statistics for categorical variables 
using counts, percentages, and frequencies. We summarized continuous variables using 
means and standard deviations.  
3.6.3! Multicollinearity 
For objectives 2, 3, and 4 of this thesis, we conducted multiple linear or logistic 
regression analyses. Prior to conducting our planned regression analyses, we assessed for 
degree of multicollinearity. Multicollinearity occurs when two or more of the 
independent variables (X1, X2, X3), that are highly correlated with one another are 
included in the same regression model and then analyzed together to predict the outcome 
(Y) (Lauridesn & Mur, 2006; Mansfield & Helms, 1982). Multicollinearity can have 
negative effects on estimation and on inference (Mansfield & Helms, 1982). We used 
Variance Inflation Factors (VIF) to assess for the presence of problematic 
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multicollinearity (VIF > 4). The exposure and potential confounding variables were 
below the selected VIF cut-off value (VIF < 4), indicating that we did not have 
problematic multicollinearity in our regression models. We should note that no standard 
VIF cut-off value exists, and various cut-off values raging from four to ten have been 
suggested and/or used in prior studies (e.g., Craney & Surles, 2002; O’Brien, 2007; Pan 
& Jackson, 2008). 
3.6.4! Analysis: Objective 1 
For objective 1, we conducted a point biserial correlation to examine the correlation at 
10-year follow-up between our two recovery outcomes, occupational activity (less than 
52 weeks of the past year vs. 52 weeks of the past year), an objective measure of 
recovery, and self-perceived recovery score, a subjective measure of recovery. We 
hypothesized that there would be a statistically significant positive association between 
occupational activity and self-perceived recovery score at 10-year follow-up. 
3.6.5! Analysis: Objective 2 
For objective 2, we conducted a simple logistic regression analysis with the duration of 
untreated psychosis as the exposure variable and occupational activity as the outcome 
variable. Additionally, we conducted a series of simple logistic regression analyses with 
each potentially confounding variable of interest as the exposure variable and 
occupational activity as the outcome variable. We then constructed two multiple logistic 
regression models that included the duration of untreated psychosis as the exposure 
variable, occupational activity as the outcome variable, and blocks of potentially 
confounding variables identified from our conceptual framework. All baseline 
confounding variables were entered as a block (Baseline-adjusted model), and all 10-year 
confounding variables were entered as a block in a separate model (10-year adjusted 
model). Both models additionally adjusted for gender and age of onset. We hypothesized 
that a longer duration of untreated psychosis would decrease the odds of engagement in 
occupational activity, adjusting for gender, age of onset, and other confounding variables.  
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3.6.6! Analysis: Objective 3 
For objective 3, we conducted a simple linear regression analysis with the duration of 
untreated psychosis as the exposure variable and self-perceived recovery score as the 
outcome variable. Additionally, we conducted a series of simple linear regression 
analyses with each potentially confounding variable of interest as the exposure variable 
and self-perceived recovery score as the outcome. We then constructed two multiple 
linear regression models that included the duration of untreated psychosis as the exposure 
variable, self-perceived recovery score as the outcome variable, and adjusted for blocks 
of confounding variables identified from our conceptual framework. All baseline 
confounding variables were entered as a block (Baseline-adjusted model) and then 
gender, age of onset, and all 10-year confounding variables were entered as a block (10-
year adjusted model) in a separate model. We hypothesized that there will be a 
statistically significant positive association between the duration of untreated psychosis 
and self-perceived recovery score, adjusting for gender, age of onset, and other 
confounding variables.  
3.6.7! Analysis: Objective 4 
For objective 4, we used the causal steps method of mediation proposed by Baron and 
Kenny (1986), in conjunction with the bootstrapping method of mediation, to determine 
whether relapse is a potential mediator in the causal pathway between the duration of 
untreated psychosis and self-perceived recovery score. We performed a series of four 
regression analyses according to the method outlined by Baron and Kenny (1986):  
(1)!Regressing self-perceived recovery score (outcome) on the duration of untreated 
psychosis (exposure);  
(2)!Regressing relapse (mediator) on the duration of untreated psychosis (exposure);  
(3)!Regressing self-perceived recovery score (outcome) on relapse (mediator), 
adjusting for the duration of untreated psychosis (exposure);   
(4)!Regressing self-perceived recovery score (outcome) on both the duration of 
untreated psychosis (exposure) and relapse (mediator). 
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If relapse is in fact a mediator, the following conditions must be met: (A) The duration of 
untreated psychosis (exposure) is significantly correlated with relapse (mediator); (B) 
Relapse (mediator) is significantly correlated with self-perceived recovery score 
(outcome); and (C) When the effect of relapse (mediator) is controlled, the significant 
relationship between the duration of untreated psychosis (exposure) and self-perceived 
recovery score (outcome) either becomes not statistically significant (i.e., full mediation) 
or greatly attenuated (i.e., partial mediation) (Baron & Kenny, 1986). We adjusted for all 
potentillay confounding variables in the mediation analysis. 
We decided to conduct the causal steps method of mediation regardless of the result (i.e., 
statistically significant or not statistically significant) of step 1. Researchers (e.g. Shrout 
and Bolger, 2002; Zhao, Lynch, & Chen, 2010), including Kenny himself (Kenney et al., 
1998) have stated that the first step can often be overlooked in many cases because the 
absence of a relationship between the exposure (X) and the outcome (Y) in the context of 
mediation can occur for several reasons (as cited in Pardo & Roman, 2013). For instance, 
Shrout and Bolger (2002) argue that the further apart the exposure (X) and outcome (Y) 
are from one another in the causal chain, the less likely the relationship (if any) between 
the two variables will be statistically significant. This may perhaps be attributed to 
unidentified suppressing or moderating variables, which are altering the relationship 
between the exposure (X) and the outcome (Y) (Mackinnon, Krull, & Lockwood, 2000; 
Shrout and Bolger, 2002).  
To assess for indirect effects, we used the bootstrap method of mediation developed by 
Preacher and Hayes (2008). As compared to traditional tests such as the Sobel test, the 
bootstrap method does not require the assumption of a normal distribution of the indirect 
effects to be met (Preacher & Hayes, 2008). Furthermore, it has been suggested to use 
bootstrap methods to assess mediation in experimental and non-experimental studies that 
have small to moderate sample sizes (Shrout & Bolger, 2002). In order to calculate the 
bias-corrected 95% confidence interval (BC 95% CI), we used 5000 bootstrap resamples. 
The indirect effect is deemed statistically significant, when the BC 95% CI does not 
contain the value of zero.  
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3.6.8! Sensitivity Analyses 
We preformed sensitivity analyses to assess the robustness of findings by conducting the 
analyses for objectives two, three, and four again, using complete data (n = 40). We also 
repeated these sensitivity analyses using the imputed data (n = 65), with the duration of 
untreated illness substituted for the duration of untreated psychosis, as the exposure 
variable in the regression models. Prior to conducting the latter sensitivity analyses, we 
assessed the distribution of the duration of untreated illness, which was positively 
skewed. For comparability of results, we normalized the duration of untreated illness 
distribution by using a square root transformation, an approach used by other researchers 
in the field (e.g., Norman et al., 2012). We used the transformed duration of untreated 
illness variable as a continuous variable in all sensitivity analyses.  
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Chapter 4!!
4! Results 
In this chapter, the sample is described in Section 4.1, including presentation of 
descriptive statistics for sociodemographic and clinical characteristics of the sample. In 
Section 4.2, findings from the attrition analysis are presented, comparing baseline 
sociodemographic and clinical characteristics between those who did and did not 
participate at 10-year follow-up. In Section 4.3, results of a bivariate analysis conducted 
for objective 1 are reported. Thereafter in Section 4.4, the results of a series of simple and 
multiple logistic regression analyses conducted for objective 2 are presented. 
Subsequently, in Section 4.5, the results of a series of simple and multiple linear 
regression analyses conducted for objective 3 are presented. Next in Section 4.6, findings 
from the mediation analysis are described. Lastly, findings from our sensitivity analyses 
are reported in Section 4.7.  
4.1! Sample 
Of the cohort of 132 clients admitted to PEPP (March 1997 to February 2002) for 
treatment of a first episode of psychosis, 56 clients were followed up at 5-years and 68 
clients were followed up at 10-years. An overview of participation at each of the three 
assessment points is presented in Figure 4.1. Although 68 clients participated at 10-year 
follow-up, we excluded three participants from analyses because they were missing data 
for one of the two outcome variables, specifically self-perceived recovery score (n = 2) or 
occupational activity (n = 1). Thus, our final sample included 65 clients (Figure 4.1). 
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Figure 4.1: Flow-Chart Outlining Participation and Non-Participation in a 
Prospective Cohort Study at Baseline, 5-Year Follow-Up, and 10-Year Follow-Up. 
Cohort of People with First-Episode Psychosis Admitted to 
PEPP (Baseline) 
(n = 132) 
Participated in 5-Year Follow-Up 
(n = 56) 
Did Not Participate in 5-Year Follow-Up 
(n = 76) 
Total Number of Clients that Participated in 10-Year 
Follow-Up Study 
(n = 68) 
Participated in 10-Year Follow-Up 
(n = 56) 
Participated in 10-Year Follow-Up 
(n = 12) 
Refused to Participate (n = 32) 
Lost to Follow-Up (n = 32) 
Missing Outcome (n = 3) 
  - Self-Perceived Recovery Score: n = 2 
  - Occupational Activity: n = 1  
Total Number of Clients Included in Analyses 
(n = 65) 
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4.1.1! Descriptive Statistics of the Sample 
The sociodemographic and clinical characteristics of the sample at baseline and 10-year 
follow-up are summarized in Tables 4.1 and 4.2, respectively. The sample was comprised 
of a higher proportion of males (75%) than females (25%). Mean age was 38.8 years (SD 
= 8.6) with a range between 26 to 60 years, and the mean duration of untreated psychosis 
was 67.4 weeks (SD = 139.3) with a range between 0.1 to 917.7 weeks. A majority of the 
participants were Caucasian (88%), were single (63%), diagnosed with a schizophrenia-
spectrum disorder (85%), lived with others (63%), generated an annual income of less 
than $10, 000 to $29,999 (80%), and reported no drug use (74%). Over half of the 
participants completed at least some post-secondary education (52%). Additionally, over 
half of the participants were employed (54%), while the remainder (46%) were 
unemployed. None of the participants identified student, homemaker, or retired as their 
employment status. 
4.2! Attrition Analysis  
An overall follow-up rate of 52% (68/132) was attained at the 10-year assessment point. 
Comparison between participants (n = 56) and non-participants (n = 76) revealed no 
statically significant differences on any of the baseline sociodemographic or clinical 
characteristics (Table 4.3). 
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Table 4.1: Sociodemographic and Clinical Characteristics of the Sample (n = 65) at 
Baseline. 
 
Note: * Included in simple and multivariable regression analyses; n = count (frequency); 
SD = Standard Deviation; DUP = Duration of Untreated Psychosis (weeks);                   
DUI = Duration of Untreated Illness (weeks); % = Percentage.  
 
 
 
 
 
 
Characteristic n (%) 
Baseline  
Gender* 
     Male 49 (75.4) 
     Female  16 (24.6) 
Mode of Onset* 
     Acute 13 (20.3) 
     Insidious  51 (79.7) 
Diagnosis of a Psychotic Disorder* 
Schizophrenia-Spectrum 55 (84.6) 
     Schizophrenia- Disorganized  3 (4.6) 
     Schizophrenia-Paranoid 17 (26.2) 
     Schizophreniform 1 (1.5) 
     Schizoaffective  10 (15.4) 
     Schizophrenia-Undifferentiated  24 (36.9) 
Other Psychotic Disorder 10 (15.3) 
     Substance-Induced Psychosis  1 (1.5) 
     Bipolar I with Psychotic Features 3 (4.6) 
     Major Depression with Psychotic Features 1 (1.5) 
     Brief Psychotic Disorder 2 (3.1) 
     Psychosis Not Otherwise Specified  3 (4.6) 
Characteristic Mean (SD) Median Range 
Age of Onset (years)*  23.9 (8.0) 21.8 10.0 to 46.5 
Premorbid Adjustment (score) 0.3 (0.2) 0.3 0.0 to 0.8 
Positive Symptoms (total global items score)* 10.4 (3.3) 10 2 to 17 
Negative Symptoms (total global items score)*  11.6 (5.2) 12 2 to 23 
DUP (weeks)* 67.4 (139.3) 23.6 0.1 to 017.7 
DUI (weeks)* 284.9 (298.6) 198.4 0.0 to 1206.7 
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Table 4.2: Sociodemographic and Clinical Characteristics of the Sample (n = 65) at 
10-Year Follow-Up. 
Characteristic n (%) 
10-year Follow-up  
Ethnicity  
     Caucasian  57 (87.7) 
     Black/African American  2 (3.1) 
     Native American/American Indian 3 (4.6) 
     Asian/Pacific Islander  2 (3.1) 
     Other  1 (1.5) 
Marital Status   
     Single (Never Married) 41 (63.1) 
     Married/Common Law  18 (27.7) 
     Divorced/Separated  5 (7.7) 
     Widowed 1 (1.5) 
Highest Level of Education Attained*  
     Less than or completed high school  31 (47.7) 
     Some post-secondary  34 (52.3) 
Living Arrangement   
     Lives Alone 24 (37.0) 
     Lives with Other(s)  41 (63.0) 
Employment Status  
     Employed 35 (53.8) 
     Unemployed 30 (46.2) 
Annual Income   
     Less than $10, 000 to $29, 999 52 (80.0) 
     $30, 000 to $49, 999  13 (20.0) 
Drug Use*  
     No 48 (73.9) 
     Yes 17 (26.1) 
Medication Adherence   
     Less than or equal to 75% 5 (8.20) 
     Greater than 75%  56 (91.80) 
Characteristic Mean (SD) Median  Range 
Age (years)  38.8 (8.6) 36 26 to 60 
Total Years of Formal Education 13.1 (2.1) 13 8 to 17 
Perceived Social Support (score)* 31.5 (6.5) 33 14 to 40 
Positive Symptoms (total global items score)* 3.8 (3.4) 3 0 to 14 
Negative Symptoms (total global items score)* 6.0 (5.5) 4 0 to 18 
Note: * Included in simple and multivariable regression analyses; n = count (frequency);           
SD = Standard Deviation; % = Percentage.  
 
 
81 
 
Table 4.3: Comparison of Baseline Sociodemographic and Clinical Characteristics 
between Participants (n = 56) and Non-Participants (n = 76) at 10-Year Follow-Up. 
 
Note: DUP = Duration of Untreated Psychosis (weeks); DUI = Duration of Untreated 
Illness (weeks); n = count; SD = Standard Deviation; % = Percentage.  
 
 
 
Characteristic Participants 
(n = 56) 
Non-Participants 
(n = 76) 
P-value  
Sociodemographic     
Gender n (%)   0.91 
     Male 43 (77) 59 (78)  
     Female  13 (23) 17 (22)  
Highest Level of Education n (%)   0.36 
     Special education  1 (1.8) 5 (6.6)  
     Less than high school diploma 24 (42.9) 34 (44.7)  
     High school diploma 11(19.6) 20 (26.3)  
     Some post-secondary  20 (35.7) 17 (22.4)  
Marital Status n (%)    0.80 
     Single  46 (82.1) 63 (82.9)  
     Married/Common Law/Stable Relationship  7 (12.5) 11 (14.5)  
     Separated  3 (5.4) 2 (2.6)  
Clinical     
Age of Onset (years) Mean (SD) 24.2(8.2) 23.5 (8.2) 0.64 
Premorbid Adjustment (score) Mean (SD) 0.3(0.2) 0.3 (0.1) 0.45 
DUP (weeks) Mean (SD) 53.5 (92.0) 88.6 (125.3) 0.45 
DUI (weeks) Mean (SD) 271.6 (289.1) 287.1 (251.5) 0.06 
Positive Symptoms (total global items) Mean (SD) 10.5 (3.2) 10.1 (3.5) 0.52 
Negative Symptoms (total global items) Mean (SD) 11.8 (5.1) 11.9 (4.9) 0.91 
Diagnosis of a Psychotic Disorder n (%)   0.54 
Schizophrenia-Spectrum    
     Schizophrenia-Disorganized  4 (7.1) 5 (6.6)  
     Schizophrenia-Paranoid 16 (28.6) 26 (34.2)  
     Schizophreniform 2 (3.6) 2 (2.6)  
     Schizoaffective  9 (16.1) 12 (15.8)  
     Schizophrenia-Undifferentiated  17 (30.3) 15 (19.7)  
Other Psychotic Disorder    
     Substance-Induced Psychosis  1 (1.8) 7 (9.2)  
     Bipolar I with Psychotic Features 2 (3.6) 5 (6.6)  
     Major Depression with Psychotic Features 1 (1.8) 0 (0.0)  
     Brief Psychotic Disorder 1 (1.8) 0 (0.0)  
     Psychosis Not Otherwise Specified  3 (5.3) 3 (3.9)  
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4.3! Objective 1 
At 10-year follow-up, participants were engaged in occupational activity for either less 
than 52 weeks of the past year (n = 33) or for 52 weeks of the past year (n = 32).  
At 10-year follow-up, the mean total self-perceived recovery score obtained by 
participants on the MARS was 106.9 (SD = 13.2). The total MARS scores ranged from 
70 to 125. The distribution of the total MARS scores within the sample (n = 65) is 
presented in Figure 4.2.
Figure 4.2: Total MARS Scores for Sample (n = 65). 
The point biserial (pbi) correlation coefficient revealed a positive association between 
self-perceived recovery score, a subjective measure of recovery, and occupational activity 
(less than 52 weeks of the year vs. 52 weeks of the year), an objective measure of 
recovery, at 10-year follow-up; however, this association was not statistically significant 
(rpbi = 0.14, P = 0.28). 
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4.4! Objective 2 
4.4.1! Variables Associated with Objective Recovery  
Table 4.4 contains the results of the unadjusted, baseline adjusted, and 10-year adjusted 
regressions models, with the duration of untreated psychosis as the exposure variable, and 
occupational activity as the outcome variable.  
Duration of Untreated Psychosis  
Across all regression models, results revealed no statistically significant association 
between the duration of untreated psychosis and occupational activity at 10-year follow-
up (Table 4.4). In the unadjusted and the baseline adjusted regression models, the 
magnitude of the odds ratio is less than one, but in the 10-year adjusted regression model, 
the magnitude of the odds ratio is greater than one.  
Highest Level of Education 
Findings from the unadjusted regression model revealed a statistically significant 
association between some post-secondary education and occupational activity at 10-year 
follow-up (OR = 3.32, 95% CI: 1.21 to 9.21). However, this result was no longer 
statistically significant in the 10-year adjusted regression model.  
Negative Symptoms Score  
In both the unadjusted and 10-year adjusted regression models, results revealed a 
statistically significant association between negative symptoms score at 10-year follow-
up and occupational activity at 10-year follow-up (OR = 0.73, 95% CI: 0.63 to 0.85; OR 
= 0.69, 95% CI: 0.57 to 0.84). In both regression models, the magnitude of the odds ratio 
was less than 1, suggesting that the odds of engagement in occupational activity in the 
past year decreases, as number of negative symptoms increases. Findings further 
indicated that the magnitude of the odds ratio slightly attenuated with the addition of 
confounding variables (Table 4.4). 
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Table 4.4: Unadjusted and Adjusted Logistic Regression Models with DUP as the Exposure Variable and Occupational 
Activity (Less than 52 weeks in past year vs. 52 weeks of the past year) as the Outcome Variable (n = 65). 
 
 
Note: * Exposure; ** Indicates statistically significant findings; OR = Odds Ratio; CI = Confidence Interval; DUP = Duration of Untreated Psychosis 
(weeks); Ref. = Reference Group; N/A = Not Applicable; A statistically significant association between occupational activity and DUP or confounding 
variables exists when the 95% CI does not contain the value of one.   
Potential Confounding 
Variables 
Value Unadjusted 
OR (95% CI) 
Baseline Adjusted 
OR (95% CI) 
10-Year Adjusted 
OR (95% CI) 
DUP* (weeks)  N/A 0.91 (0.77 to 1.20) 0.91 (0.67 to 1.26) 1.26 (0.81 to 1.95) 
Baseline     
Gender Male Ref. Ref. Ref. 
Female 1.34 (0.43 to 4.18) 1.05 (0.30 to 3.74) 1.90 (0.31 to 11.59) 
Age of Onset (years) N/A 1.03 (0.97 to 1.09) 1.03 (0.95 to 1.12) 0.97 (0.87 to 1.07) 
Mode of  
Onset 
Acute Ref. Ref. - 
Insidious 0.33 (0.09 to 1.21) 0.31 (0.08 to 1.26) - 
Diagnosis of a Psychotic Disorder  Other Psychotic Disorder Ref. Ref. - 
Schizophrenia-Spectrum  0.38 (0.09 to 1.65) 0.48 (0.10 to 2.29) - 
Positive Symptoms (score) N/A 0.92 (0.79 to 1.08) 0.93 (0.79 to 1.12) - 
Negative Symptoms (score) N/A 0.99 (0.90 to 1.08) 1.04 (0.92 to 1.17) - 
10-year Follow-up      
Highest Level of Education Less than or Completed 
High School 
Ref. - Ref. 
Some Post-Secondary 3.32 (1.21 to 9.21)** - 2.89 (0.67 to 12.30) 
Perceived Social Support (score) N/A 1.13 (1.02 to 1.23)** - 1.13 (1.00 to 1.28) 
Drug Use No Ref. - Ref. 
Yes 0.82 (0.27 to 2.48) - 0.29 (0.05 to 1.72) 
Positive Symptoms (score) N/A 0.86 (0.73 to 1.01) - 0.86 (0.69 to 1.07) 
Negative Symptoms (score) N/A 0.73 (0.63 to 0.85)** - 0.69 (0.57 to 0.84)** 
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Perceived Social Support Score  
Findings from the unadjusted regression model (OR = 1.13, 95% CI: 1.02 to 1.23) 
indicated a statistically significant association between perceived social support score at 
10-year follow-up and occupational activity at 10-year follow-up, but the association was 
no longer statistically significant association in the 10-year adjusted regression model. 
4.5! Objective 3 
4.5.1! Variables Associated with Subjective Recovery 
Table 4.5 summarizes the results of the unadjusted, baseline adjusted, and 10-year 
adjusted regression models, with the duration of untreated psychosis as the exposure 
variable, and self-perceived recovery score as the outcome variable.  
Duration of Untreated Psychosis 
Results revealed no statistically significant association between the duration of untreated 
psychosis and self-perceived recovery score at 10-year follow-up across all regression 
models (Table 4.5). In general, findings indicated that the magnitude of the effect is 
attenuated with the addition of confounding variables.   
Negative Symptom Score  
Findings indicated a statistically significant association between negative symptom score 
at 10-year follow-up and self-perceived recovery score at 10-year follow-up in the 
unadjusted regression model (β = -0.71, 95% CI: -1.29 to -0.13), but not in the 10-year 
adjusted regression model (Table 4.5). 
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Table 4.5: Unadjusted and Adjusted Linear Regression Models with DUP as the Exposure Variable and Self-Perceived 
Recovery Score as the Outcome Variable (n = 65). 
 
 
 
 
 
 
 
 
 
 
 
Note: * Exposure; ** Indicates statistically significant findings; β = Beta Coefficient; CI = Confidence Interval; DUP = Duration of Untreated Psychosis 
(weeks); Ref. = Reference Group; N/A = Not Applicable; A statistically significant association between self-perceived recovery score and DUP or  
confounding variables exists when the 95% CI does not contain the value of zero.
Potential Confounding 
Variables  
Value Unadjusted 
β (95% CI) 
Baseline Adjusted 
β (95% CI) 
10-Year Adjusted 
β (95% CI) 
DUP* (weeks)  N/A -1.24 (-3.04 to 0.56) -1.57 (-3.50 to 0.36) -0.73 (-2.42 to 0.97) 
Baseline     
Gender Male Ref. Ref. Ref. 
Female -2.49 (-10.14 to 5.16) -3.61 (-11.83 to 4.60) -5.07 (-12.45 to 2.31) 
Age of Onset (years) N/A 0.00 (-0.42 to 0.43) 0.08 (-0.41 to 0.57) 0.10 (-0.32 to 0.53) 
Mode of  
Onset 
Acute Ref. Ref. - 
Insidious -5.75 (-13.69 to 2.20) -7.31 (-15.65 to 1.03) - 
Diagnosis of a Psychotic Disorder  Other Psychotic 
Disorder 
Ref. Ref. - 
Schizophrenia-Spectrum  -0.78 (-9.95 to 8.38) 1.25 (-8.56 to 11.05) - 
Positive Symptoms (score) N/A 0.39 (-0.63 to 1.41) 0.44 (-0.67 to 1.55) - 
Negative Symptoms (score) N/A 0.09 (-0.55 to 0.73) 0.11 (-0.65 to 0.87) - 
10-year Follow-up      
Highest Level of Education Less than or Completed 
High School 
Ref. - Ref. 
Some Post-Secondary 5.00 (-1.50 to 11.50) - 2.99 (-3.21 to 9.19) 
Perceived Social Support (score) N/A 1.01 (0.55 to 1.27)** - 0.94 (0.45 to 1.42)** 
Drug Use No Ref. - Ref. 
Yes 3.43 (-4.05 to 10.90) - 2.51 (-4.32 to 9.35) 
Positive Symptoms (score) N/A -0.40 (-1.37 to 0.57) - 0.14 (-0.79 to 1.07) 
Negative Symptoms (score) N/A -0.71 (-1.29 to -0.13)** - -0.36 (-0.95 to 0.24) 
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Perceived Social Support Score  
In both the unadjusted and 10-year adjusted regression models, results revealed a statistically 
significant association between perceived social support score at 10-year follow-up and self-
perceived recovery score at 10-year follow-up (β = 1.01, 95% CI: 0.55 to 1.27; β = 0.94, 95% 
CI: 0.45 to 1.42). In both regression models, the direction of the effect was positive, which 
suggests that as social support increases, self-perceived recovery increases. Results further 
revealed that the magnitude of the effect slightly attenuated with the addition of confounding 
variables (Table 4.5). 
4.6! Objective 4 
Figure 4.3 visually illustrates our mediation analysis.     
        A. Unmediated Model 
 
           
 
        B. Mediated Model 
  
 
 
 
  
Figure 4.3: Hypothesized Mediation Model with Relapse as the Mediator in the 
Relationship between DUP and Self-Perceived Recovery Score. Note: DUP = Duration of 
Untreated Psychosis; X = Exposure; Y = Outcome; M = Mediator. A. Unmediated model: Path c 
illustrates the total effect of DUP on self-perceived recovery score (no mediator). B. Mediated 
model: Path a illustrates the direct effect of DUP on relapse. Path b illustrates the direct effect of 
relapse on self-perceived recovery score after controlling for DUP. Path c’ depicts the direct 
effect of DUP on self-perceived recovery score after controlling for relapse.
Self-Perceived 
Recovery Score (Y) 
DUP 
(X) 
c 
Self-Perceived 
Recovery Score (Y) 
Relapse 
(M) 
DUP  
(X) 
c’ 
a b 
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The results of each of the four regression analyses corresponding to the four steps of the 
causal steps method of mediation (Baron & Kenny, 1986) are presented in Table 4.6. 
Regression analyses for all four steps were not statistically significant, suggesting no 
evidence of a mediating effect of relapse on the association between the duration of 
untreated psychosis and self-perceived recovery score. 
Table 4.6: Testing for Mediation Using the Causal Steps Methods of Mediation         
(n = 65). 
Note: DUP = Duration of Untreated Psychosis; X = Exposure = DUP (weeks); Y = 
Outcome = Self-Perceived Recovery Score; M = Mediator = Relapse; β = Beta 
Coefficient. The direct effects are statistically significant at the 95% confidence interval 
(CI), when the 95% CI does not include 0.  
Findings from the bootstrap method of mediation (Preacher & Hayes, 2008) indicated 
that the indirect effect of the duration of untreated psychosis on self-perceived recovery 
score via relapse is not statistically significant (β = -0.00, BC 95% CI: -0.34 to 0.23). 
4.7! Sensitivity Analyses 
4.7.1! Sensitivity Analyses for Complete Data  
4.7.1.1! Objective 2 
In contrast to the main analyses, results from the sensitivity analyses with participants 
who had complete data (n = 40) revealed that the magnitude of the odds ratio for the 
duration of untreated psychosis across all three regression models were slightly larger, 
and the corresponding 95 % CI’s were slightly wider, but remained non-significant.  
Step (Regression Analysis) Variable 
(Exposure) 
β [95% CI]  
(Exposure) 
Pathway 
(Figure 4.3) 
1.! Conduct a regression analysis with X and Y. DUP -1.12 (-2.88 to 0.64) c 
2.! Conduct a regression analysis with X and M. DUP -0.16 (-0.39 to 0.07) a 
3.! Conduct a regression analysis with M and Y, adjusting for X. Relapse 0.04  (-2.26 to 2.34) b 
4.! Conduct a regression analysis with X and Y, adjusting for M. DUP -1.17 (-3.00 to 0.65) c’ 
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All other findings were consistent with the findings from the main analyses.  
4.7.1.2! Objective 3 
In contrast to the main analyses, results from the sensitivity analyses with participants 
who had complete data (n = 40) revealed that in the unadjusted (β = -1.29, 95% CI: -3.86 
to 1.28) and baseline adjusted  (β = 2.12, 95% CI: -5.04 to 0.80) regression models, the 
magnitude of the effect of the duration of untreated psychosis was larger and the 
corresponding 95% CI’s were wider but remained non-significant. In the 10-year adjusted 
regression model (β = -0.38, 95% CI: -2.68 to 1.92), the magnitude of the effect of the 
duration of untreated psychosis was smaller and the corresponding 95% CI was narrower.   
In contrast to the findings of the main analyses, findings from the 10-year adjusted 
regression model revealed a statistically significant association between negative 
symptoms score at 10-year follow-up and self-perceived recovery score at 10-year 
follow-up (β = -1.04, 95% CI: -1.75 to -0.32). In the unadjusted (β = -1.28, 95% CI: -1.94 
to -0.63) and 10-year adjusted  (β = -1.04, 95% CI: -1.75 to -0.32) regression models, the 
magnitude of the effect was larger and the corresponding 95% CI’s were wider than those 
in the main analyses.  
All other findings were consistent with the findings of the main analyses.  
4.7.1.3! Objective 4 
Findings from the sensitivity analyses using participants with complete data (n = 40) to 
assess the hypothesized mediation model are consistent with the main findings using 
imputed data. 
4.7.2! Sensitivity Analyses for Measure of Untreated Illness 
4.7.2.1! Objective 2 
In contrast to the findings from the main analyses with the duration of untreated 
psychosis as the exposure variable, findings from the sensitivity analyses with the 
duration of untreated illness as the exposure variable revealed a statistically significant 
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association between the duration of untreated illness and occupational activity at 10-year 
follow-up in the unadjusted (OR = 0.93, 95% CI: 0.88 to 0.99) and baseline adjusted  
(OR = 0.92, 95% CI: 0.86 to 0.99) regression models. In the 10-year adjusted regression 
model, the magnitude of the odds ratio for the duration of untreated psychosis was less 
than one, which suggests that the odds of engagement in occupational activity in the 
previous year decreases as the duration of untreated illness increases.   
All other findings were consistent with the findings of the main analyses.  
4.7.2.2! Objective 3 
In contrast to the findings from the main analyses with the duration of untreated 
psychosis as the exposure variable, findings from the sensitivity analyses with the 
duration of untreated illness as the exposure variable revealed a statistically significant 
association between the duration of untreated illness and self-perceived recovery score at 
10-year follow-up in the unadjusted (β = -0.66, 95% CI: -1.00 to -0.33), baseline adjusted 
(β = -0.65, 95% CI: -1.03 to -0.28), and 10-year adjusted (β = -0.52, 95% CI: -0.87 to -
0.16) regression models. These findings suggest that as the duration of untreated illness 
increase, self-perceived recovery decreases. Across all models, the magnitude of the 
effect was smaller and the corresponding 95% CI’s were narrower.  
4.7.2.3! Objective 4 
In contrast to the main analyses, findings from the sensitivity analyses that included the 
duration of untreated illness as the exposure variable in the hypothesized mediation 
model revealed that steps 1 and 4 of the causal steps method of mediation were 
statistically significant.  
All other findings were consistent with the main analyses.  
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Chapter 5!!
5! Discussion & Conclusion  
In this final chapter, key findings from the analyses conducted for each of the four 
objectives of this thesis are discussed in the context of existing literature. Section 5.1 
begins with a discussion of the findings from the bivariate analysis examining the 
association between the two recovery outcomes at 10-year follow-up (Objective 1). Next, 
the findings from multiple logistic and linear regression analyses investigating whether 
the duration of untreated psychosis is associated with occupational activity (objective 
recovery) and/or self-perceived recovery score (subjective recovery) at 10-year follow-
up, adjusting for confounding variables (Objectives 2 & 3) are discussed. Subsequently, 
findings from the mediation analysis investigating whether relapse mediates the 
relationship between the duration of untreated psychosis and self-perceived recovery 
score at 10-year follow-up (Objective 4) are discussed. Next in Section 5.2, evidence 
from previous studies reporting a differential relationship of the duration of untreated 
psychosis and the duration of untreated illness to particular outcome measures is 
provided. Thereafter in Section 5.3, the strengths of this thesis are discussed, followed by 
a discussion of the limitations in Section 5.4. Finally, clinical implications are discussed 
in Section 5.5, and an overall conclusion is provided in Section 5.6.  
5.1! Summary of Key Findings by Study Objective 
5.1.1! Objective 1 
Several empirical studies have investigated the relationship between objective and 
subjective recovery from psychotic disorders (e.g., schizophrenia) or other serious mental 
illness (Jørgensen et al., 2015; Kukla, Lysaker, & Roe, 2014; Lloyd, King, & Moore, 
2010; Morland, 2007; Norman, Windell, & Manchanda, 2013; Resnick, Rosenheck, & 
Lehman, 2004; Roe, Mashiach-Eizenberg & Lysaker, 2011). However, findings from 
these studies have been equivocal, with evidence for and against the presence of an 
association between these two dimensions of recovery. Given these inconsistent findings, 
we sought to examine the association between our two 10-year outcomes of interest, 
specifically objective and subjective recovery from a first episode of psychosis. We 
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hypothesized that there would be a statistically significant positive association between 
occupational activity and self-perceived recovery score at 10-year follow-up, such that 
people who attained objective recovery would have higher self-perceived recovery 
scores. Results revealed a positive association between occupational activity, our 
objective measure of recovery, and self-perceived recovery score, our subjective measure 
of recovery; however, contrary to our hypothesis, the positive association was not 
statistically significant. This finding is consistent with results of previous studies (Kukla, 
Lysaker, & Roe, 2014; Roe, Mashiach-Eizenberg & Lysaker, 2011), suggesting that self-
assessment of recovery from first-episode psychosis and other psychotic disorders is 
independent of occupational activity, symptom severity (Roe, Mashiach-Eizenberg & 
Lysaker, 2011), level of functioning (Roe, Mashiach-Eizenberg & Lysaker, 2011), and 
the presence of positive and negative symptoms (Kukla, Lysaker, & Roe, 2014), which 
are all objective measures of recovery. In other words, one’s perception of recovery is not 
determined by some persisting, overt, and measureable characteristics that have been 
compromised by or associated with the diagnosis itself.    
Inconclusive evidence regarding the presence or absence and direction of an association 
between objective and subjective recovery may perhaps be attributed to the following 
differences: 1) How objective and subjective recovery are operationalized and measured; 
and 2) Number of assessment points.   
1. Operationalization and Measurement of Subjective and Objective Recovery. 
Variability in the operationalization and measurement of subjective and objective 
recovery across studies precludes comparability because the same construct is not being 
assessed. In some studies, operationalization of subjective and objective recovery may 
refer to total scores (Kukla, Lysaker, & Roe, 2014; Morland, 2007; Roe, Mashiach-
Eizenberg & Lysaker, 2011), individual domains/subscales (Norman, Windell, & 
Manchanda, 2013; Resnick, Rosenheck, & Lehman, 2004), or a combination of total 
scores and individual domains/subscales (Jørgensen et al., 2015; Llyod, King, & Moore, 
2010) of the measures used to assess subjective and objective recovery. Subjective 
recovery (i.e., self-reported recovery) has been assessed with different measures - in this 
thesis we used the MARS (total score), whereas others have used the Recovery 
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Assessment Scale (Jørgensen et al., 2015; Kukla, Lysaker, & Roe, 2014; Lloyd, King, & 
Moore, 2010; Norman, Windell, & Manchanda, 2013; Roe, Mashiach-Eizenberg & 
Lysaker, 2011) or the Mental Health Recovery Scale (Morland, 2007). Furthermore, 
objective recovery in this thesis was defined by occupational activity (less than 52 weeks 
of past year vs. 52 weeks of past year), in other studies, objective recovery refers to the 
assessment or severity of symptoms. (Kukla, Lysaker, & Roe, 2014; Morland, 2007; 
Norman, Windell, & Manchanda, 2013; Resnick, Rosenheck, & Lehman, 2004; Roe, 
Mashiach-Eizenberg & Lysaker, 2011). The measures used to assess objective recovery 
defined by symptoms or the severity of symptoms also varies across studies. For instance, 
Kukla and colleagues (2014) and Morland (2007) used the Positive and Negative 
Symptoms Scale, whereas Norman and colleagues (2013) used the SAPS and SANS, 
while Resnick and colleagues (2004) used the shortened version of the Symptom 
Checklist, and Roe and colleagues (2011) used the Brief Psychiatric Rating Scale 
Expanded. Future studies should therefore adhere to the same operationalization of 
objective and subjective recovery, as well use consistent recovery measures to allow 
comparison of findings across studies.  
2. Number of Assessment Points. Assessment of objective and subjective recovery at a 
single time-point does not capture the fluctuating nature of recovery over time. A 
majority of studies, including this thesis, assessed the relationship between objective and 
subjective recovery at a single time-point (Kukla, Lysaker, & Roe, 2014; Lloyd, King, & 
Moore, 2010; Morland, 2007; Norman, Windell, & Manchanda, 2013; Resnick, 
Rosenheck, & Lehman, 2004; Roe, Mashiach-Eizenberg & Lysaker, 2011), whereas the 
study conducted by Jørgensen and colleagues (2015) assessed the relationship across 
multiple time-points, which allowed them to assess change over time. In the latter study, 
fluctuation in the presence or absence of a relationship between domains of self-reported 
recovery (subjective recovery) and domains of symptoms (objective recovery) was found 
across the four time points. Future studies should therefore assess recovery at multiple 
time-points to capture its changing state.  
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5.1.2! Objective 2 
Austin and colleagues (2013) conducted the only study to date that investigated whether 
the duration of untreated psychosis is associated with objective recovery among people 
with first-episode psychosis over a long follow-up period (>10-years). To add to this 
essentially non-existent body of literature, we sought to investigate whether duration of 
untreated psychosis is associated with occupational activity (objective recovery), 10-
years after a first episode of psychosis. We hypothesized that a longer duration of 
untreated psychosis would decrease the odds of engagement in occupational activity, 
adjusting for gender, age of onset, and other confounding variables. Contrary to our 
hypothesis, results revealed a statistically non-significant association between duration of 
untreated psychosis and occupational activity (objective recovery) with or without 
controlling for confounding variables, suggesting that duration of untreated psychosis is 
not associated with objective recovery at 10-year follow-up among people with first-
episode psychosis. Our finding is consistent with the findings reported by Austin and 
colleagues (2013); however, objective recovery was operationalized differently in each 
study. In this thesis, we operationalized objective recovery (i.e., occupational activity) as 
engagement in work and/or school on a full-time or part-time basis for less than 52 weeks 
of the past year or for 52 weeks of the past year. In the study conducted by Austin and 
colleagues (2013) with 304 people with first-episode psychosis, objective recovery was 
differentiated into full and functional recovery. Functional recovery was defined as 
currently engaged in work/study, a Global Assessment of Functioning-Functioning Scale 
score over 60, and no psychiatric hospitalizations or living in supported housing for the 
past two years (Albert et al., 2011). Full recovery was defined as stable remission of both 
negative and positive symptoms and functional recovery (Liberman & Kopelowicz, 
2005).  
Comparison of our finding to other studies that used occupational activity as an outcome 
measure suggest that perhaps there is a relationship between the duration of untreated 
psychosis and objective recovery for shorter follow-up periods. Major and colleagues 
(2010), in a 1-year follow-up of 114 people with first-episode psychosis, found that 
longer duration of untreated psychosis decreased the likelihood of gaining or returning to 
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competitive employment or an educational activity that has led to a nationally recognized 
vocational qualification or degree (i.e., vocational recovery). Similarly, Norman and 
colleagues (2007) reported that a shorter duration of untreated psychosis was 
significantly associated with more occupational activity at 3-year follow-up among 163 
people with first-episode psychosis, after adjusting for other confounding variables. 
However, in a 5-year prospective study with the same cohort of participants (n = 132) 
used in this thesis, the association between the duration of untreated psychosis and 
occupational activity was not assessed in subsequent regression analyses because the 
negative bivariate association was not statistically significant (Norman et al., 2012). 
Aside from differences in length of follow-up, other possible explanations for 
discrepancies in findings include the criteria used to define occupational activity, and the 
stratification of duration of untreated psychosis as long or short.  
Interestingly, results demonstrated that after adjusting for all confounding variables, the 
only statistically significant factor associated with occupational activity (objective 
recovery) at 10-year follow-up was negative symptoms score, with lower negative 
symptom scores at 10-year follow-up associated with increased likelihood of engagement 
in occupational activity (objective recovery) for 52 weeks of the past year at 10-year 
follow-up. Our finding extends previous findings of a 5-year prospective study that 
revealed a statistically significant, negative association between weeks of occupational 
activity and two dimensions of negative symptoms (i.e., reduced motivation and 
expressiveness) among the same cohort of participants (n = 132) used in this thesis. 
(Norman, Manchanda, Harricharan, & Northcott, 2015). Taken together, these findings 
suggest that the less negative symptoms a person with first-episode psychosis 
experiences, the more engaged (number of weeks) he or she will be in work and/or school 
on a full-time or part-time basis. 
5.1.3! Objective 3 
To our knowledge, no study to date has examined the association between the duration of 
untreated psychosis and subjective recovery. We hypothesized that there will be a 
statistically significant negative association between the duration of untreated psychosis 
and self-perceived recovery score at 10-year follow-up, such that longer duration of 
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untreated psychosis would be associated with lower self-perceived recovery scores, after 
adjusting for gender, age of onset, and other confounding variables. Results revealed a 
negative association between duration of untreated psychosis and self-perceived recovery 
score (subjective recovery) at 10-year follow-up, controlling for confounding variables. 
However, we acknowledge that we conducted a secondary analysis of data, and our study 
was not designed or powered to look at the association between DUP and self-perceived 
recovery score. Therefore, we cannot determine if there was a negative association or 
lack of power to detect one.  
5.1.4! Objective 4 
Vulnerability to relapse has been perceived, by some, to impede one’s recovery from a 
first episode of psychosis (Maddigan, 2011; Windell, Norman, & Malla, 2012), and it has 
also been found to be a consequence of a long duration of untreated psychosis (Saravanan 
et al., 2010; Stefanescu, Macrea, Popescu, Ilies, & Miclutia, 2013). We thus sought to 
investigate whether relapse mediates the relationship between the duration of untreated 
psychosis (exposure) and self-perceived recovery score (subjective recovery; outcome), 
and found no evidence of mediation. Specifically, we noted an absence of a statistically 
significant relationship between our exposure and our outcome, which perhaps is 
attributed to latency since we assessed our exposure at baseline and our outcome at 10-
year follow-up. We also noted there was no statistically significant relationship between 
duration of untreated psychosis and relapse, which is inconsistent with previous findings 
(Saravanan et al., 2010; Stefanescu, Macrea, Popescu, Ilies, & Miclutia, 2013). A 
possible explanation for the discrepancy is that the duration of untreated psychosis may 
be more strongly associated with relapse during the first 5-years (i.e., baseline to 5-year 
follow-up), for which we did not have data available on hospitalizations during this 
period of time.  
We additionally noted that there was no statistically significant relationship between 
relapse and self-perceived recovery score at 10-year follow-up (subjective recovery). It is 
possible that factors such as medication discontinuation may further mediate the 
relationship between relapse and self-perceived recovery (Windell, Norman, & Malla, 
2012).  
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The lack of evidence for mediation may perhaps be attributed to our use of a less 
accurate, non-inclusive measure of relapse. We used hospitalization data as a proxy 
measure of relapse, and the use of these data as an indicator of relapse among people with 
first-episode psychosis using a specialization early intervention service has only 47% 
specificity (Addington, Patten, McKenzie, & Addington, 2013).  
We also did not have complete data available on hospitalizations occurring between 
baseline and 5-year follow-up, and therefore did not include this information in our 
analyses. We thus may have underestimated relapse because 80% of people who 
experience a first episode of psychosis will experience a relapse during the 5-year period 
after the first-episode (Gitlin, 2001; Robinson et al., 1999; Wiersma, Nienhuis, Slooff, & 
Giel, 1998). 
5.2! DUI vs. DUP: Relationship to Outcomes 
The duration of untreated psychosis was not found to be statistically associated with 
either of the two recovery outcomes in our main analyses, whereas, the duration of 
untreated illness was found to be statically associated with both of the recovery outcomes 
in our sensitivity analyses. This finding is consistent with previous studies that have 
found the duration of untreated illness, rather than the duration of untreated psychosis, to 
be more consistently associated with certain outcomes (Crumlish et al., 2009; Harris et 
al., 2005; Keshavan et al., 2003; Norman et al., 2012). For instance, the duration of 
untreated illness has been reported to be more consistently associated with negative 
symptoms, levels of functioning, use of a disability pension, and social and occupational 
functioning at 2-, 5-, and/or 8-year follow-up (Crumlish et al., 2009; Harris et al., 2005; 
Keshavan et al., 2003; Norman et al., 2012). Thus, the duration of untreated illness has a 
differential relationship with particular outcome measures, including recovery at 10-year 
follow-up.  
5.3! Strengths 
Our study has several strengths. It uses a prospective study design, which allowed us to 
not only assess multiple recovery outcomes simultaneously, but also assess the temporal 
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relationship between the exposure (i.e., duration of untreated psychosis) and the 
outcomes (i.e., objective and subjective recovery). Our prospective study was unique 
because to our knowledge, no prospective study with a 10-year follow-up period has been 
conducted in Canada, and no study to date has examined the association between the 
duration of untreated psychosis and subjective recovery. In contrast to other prospective 
or retrospective studies that assess one type of recovery outcome among people with 
first-episode psychosis (e.g. Faber et al., 2011; Gumley et al., 2014; Major et al., 2010), 
we assessed both types of recovery outcomes, that is, objective and subjective recovery, 
We also used a standardized definition of recovery (i.e., SAMHSA definition), as well as 
a standardized and validated measure of self-perceived recovery that is specific to people 
with serious mental illness (i.e., MARS). We adhered to the recommendations made by 
Compton and colleagues (2007) with respect to the measurement of the duration of 
untreated psychosis, which involves the use of a standardized, structured interview 
assessment (i.e., CORS), and the integration of information from multiple informants 
(i.e., consensus-based estimate). We used multivariable regression analyses, which 
allowed us to assess the independent effect of our exposure of interest (duration of 
untreated psychosis), controlling for known confounding variables. Our choice of 
variables to be included as confounding variables in our regression analyses was guided 
by our conceptual framework we created based on findings from previous studies in the 
literature. Lastly, we conducted two sets of sensitivity analyses to assess the robustness of 
findings. 
5.4! Limitations 
Several methodological limitations in this study merit consideration in conjunction with 
suggestions for future studies. Follow-up data was not available for 52% (68/132) of 
participants, as they either refused to participate or were lost to follow-up. However, this 
attrition rate of 52% is comparable to other prospective studies with long follow-up 
periods (> 10-years), including those conducted by Wunderink and colleagues (2009), 
and Albert and colleagues (2011), who reported attrition rates of 49% and 54%, 
respectively.   
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Given the 52% attrition rate, we acknowledge that the sample for this thesis was small in 
size. The sample consisted of 68 participants, but we excluded three participants because 
they were missing one of the two recovery outcome variables, for a final sample of 65 
participants. The use of a small sample size in all analyses reduced the statistical power 
of the study. Findings need to be replicated with a larger sample.  
The combination of a small sample size, and the higher proportion of males than females 
comprising the sample, precluded us from conducting subgroup analyses by gender. 
Gender differences exist with respect to sociodemographic and clinical presentations 
(ElTayebani, ElGamal, Roshdy, & Al-Khadary, 2014; Thorup et al., 2014), as well as 
recovery (Thorup et al., 2014). Given that that males with first-episode psychosis have 
significantly higher levels of negative symptoms at all times of follow-up (Thorup et al., 
2014), and that females are more likely to reach a state of recovery (Thorup et al., 2014), 
it would be interesting to investigate whether females report more objective recovery, 
based on our finding of an inverse relationship between negative symptoms at 10-year 
follow-up and objective recovery at 10-year follow-up. Future research should investigate 
gender differences with respect to recovery using a larger sample that is comprised of 
roughly equal proportions of males and females.  
We acknowledge that the sample, recruited from an early intervention service (outpatient 
service) was not only predominantly male, but also predominantly Caucasian. Thus, these 
sample characteristics may limit the generalizability of our results. Specifically, our 
findings may not generalize to people receiving care from other health and social service 
providers, females, people with affective psychotic disorders, or to different ethnic 
groups who may have different definitions or concepts of subjective recovery. Thus, 
replication of findings with a sample that addresses these sample characteristics is 
needed.  
Another limitation of this study is that we did not use all of the data that we had for the 
65 participants. We had to exclude variables collected at 5-year follow-up including 
positive and negative symptoms, medication adherence, drug use, and number of hospital 
admissions. We also excluded drug use collected at baseline. Theses variables were 
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excluded from all analyses because the mechanism of missing data was assumed to be 
Missing Not At Random since they are all from the 5-year follow-up assessment. We 
were thus unable to impute these variables because the mechanism of missing data 
assumption required for multiple imputation (i.e., Missing At Random) was violated. The 
exclusion of these variables from all analyses may have altered the associations observed.  
We also removed premorbid adjustment score at baseline and medication adherence at 
10-year follow-up from all analyses post-hoc because of the lack of variability in scores 
and ratings, attributed in part to how these variables were measured. The exclusion of 
these variables from our analyses may have altered the associations observed. 
The combination of a large number of potential confounding variables and the small 
sample size, precluded us from conducting fully-adjusted multivariable regression 
models. We were therefore unable to assess the true association between duration of 
untreated psychosis and the recovery outcomes because we did not control for all known 
confounding variables. It is possible that after controlling for all known confounding 
variables, a statistically significant association between the duration of untreated 
psychosis and the recovery outcomes may have been observed.  
We acknowledge that the duration of untreated psychosis was assessed retrospectively, 
which means there is a high probability of recall bias from the participant and other 
sources of information (e.g., family), especially for a participant with a longer duration of 
untreated psychosis, and those who were experiencing a higher level of psychotic 
symptoms at the time of assessment (Compton et al., 2007).  
In contrast to other studies (e.g., Primavera et al., 2012; Tang et al., 2014), we included 
the duration of untreated psychosis as a continuous variable in all analyses, therefore 
assuming a linear relationship between the duration of untreated psychosis and outcome. 
However, other researchers dichotomize the duration of untreated psychosis (e.g., 
Primavera et al., 2012; Tang et al., 2014), assuming that the likelihood that the duration 
of untreated psychosis will have a negative impact on outcome increases when the 
duration of untreated psychosis crosses a particular threshold (Singh, 2007). Various 
threshold values in have been proposed and used to dichotomize the duration of untreated 
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psychosis as “short” or “long” including less than or greater than 31 days, 3-, 6-, or 12- 
months (Primavera et al., 2012). Perhaps if we had used the duration of untreated 
psychosis as a dichotomous variable in all analyses, the findings may have been different. 
We thus recommend future studies to follow Primavera and colleagues (2012) approach 
of including the duration of untreated psychosis as a continuous and dichotomous 
variable in all regression analyses to examine the impact on findings.  
Another limitation was that data for our two recovery outcomes was only available for 
10-year follow-up since both recovery outcomes were not assessed at baseline or at 5-
year follow-up. Given that recovery is a fairly changeable state (Albert et al., 2011), it is 
possible that our findings may have been different if we examined the relationship with 
our recovery outcomes at multiple time-points across the 10-year follow-up period. 
Future studies should thus assess recovery outcomes at multiple time points over the 
follow-up period in order to capture the changing state of recovery. Furthermore, we 
were unable to use a validated instrument to measure occupational activity, our objective 
measure of recovery, since no such measure exists.  
We acknowledge that we dichotomized our continuous objective recovery outcome and 
as a consequence we have lost statistical power and that results may potentially be biased 
by our use of a data-derived cut-point value (Naggara et al., 2011).  
Another limitation was that perceived social support was only assessed at 10-year follow-
up. We had to assume that perceived social support remains constant throughout the 10-
year follow-up period, even though it likely fluctuates, particularly in relation to illness 
trajectories.  
We also note that we used a less accurate measure of relapse, specifically hospitalization 
data (Section 3.1.4). Future research would benefit from using a more accurate measure 
of relapse such as the recurrence of the positive symptoms of psychosis. It would then 
possible to examine the influence of time to relapse and the number of relapses (recurrent 
relapses) on the associations of interest.  
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We further note that objective recovery may have been misclassified for older adults in 
our sample who were nearing retirement age. However, we had very few people who 
were over the age of 50 (n = 3), therefore this is unlikely to have impacted our findings.  
5.5! Clinical Implications 
A clinical implication from this thesis is that there is value in concurrently assessing 
different dimensions of recovery to attain a more comprehensive overview of a person’s 
recovery after a first episode of psychosis. Furthermore, the finding that negative 
symptoms are statistically associated with objective recovery at 10-year follow-up can 
directly inform clinical practice by way of targeting the reduction and/or elimination of 
negative symptoms to enhance one’s functional status (Austin et al., 2013; Emsley, 
Chiliza, & Schoeman, 2008). Similarly, the finding that perceived social support is a 
statistically associated with subjective recovery at 10-year follow-up can also directly 
inform clinical practice by way of fostering social support to enhance one’s subjective 
recovery (Austin et al., 2013; Emsley, Chiliza, & Schoeman, 2008).  
5.6! Conclusion 
To our knowledge, this thesis was not only the first prospective study with a long follow-
up period of 10-years to be conducted in Canada, but also the first study to examine 
whether the duration of untreated psychosis is statistically associated with subjective 
recovery among people with a first episode of psychosis, making it a unique contribution 
to the existing literature. Our findings suggest that factors other than the duration of 
untreated psychosis have an impact on objective and subjective recovery outcomes at 10-
year follow-up. Specifically, negative symptoms have an impact on objective recovery, 
while perceived social support has an impact on subjective recovery at 10-year follow-up.  
Further research examining factors associated with self-perceived recovery after a first 
episode of psychosis is warranted.   
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Appendices  
Appendix A: Synonyms for Duration of Untreated Psychosis & Subjective 
Recovery. 
 
Duration of Untreated Psychosis Subjective Recovery 
-! Treatment Delay 
-! Delay in Treatment 
-! Latency in Treatment  
-! Duration of Initially Untreated 
Psychosis 
-! Subjective Perceptions of Recovery 
-! Subjective Perceived Recovery 
-! Self-Rated Recovery 
-! Self-Perceived Recovery  
-! Self-Described Recovery  
-! Personal Recovery  
-! Subjective Judgments of Recovery 
from Psychosis  
-! Perceived Recovery 
-! Consumer-Defined Recovery  
-! Self-Rated Perceptions of Recovery  
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